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ABSTRACT 
Current methods for the risk assessment of environmental exposures commonly 
involve questionnaires, stationary monitoring, and personal air sampling.  However, as 
these approaches do not capture the body's internal response, they lend minimal 
understanding to the biologic consequence of exposure.  In order to address the unmet 
need of connecting external exposure measurements with signatures of internal exposure, 
this thesis examines the overarching hypothesis that transcriptomic changes in the human 
airway epithelium can serve as indicators of physiologic responses to inhaled pollutants.  
This is an extension of previous work that has demonstrated an airway ''field of injury'' 
effect where cigarette smoke exposure alters gene-expression in epithelial cells lining the 
respiratory tract.  Specifically, I examine transcriptomic changes and the biologic 
responses associated with exposure to the following pollutants: environmental tobacco 
	  	   viii 
smoke (Aim 1), household air pollution from smoky coal combustion (Aim 2), and 
electronic cigarette vapor (Aim 3).   
First, I performed whole-genome transcriptional profiling of the nasal epithelium 
in children and adults and detected gene-expression changes associated with exposure to 
environmental tobacco smoke.  Next, I employed similar approaches to detect a signature 
of coal smoke exposure in the buccal epithelium of healthy, non-smoking females 
exposed to household air pollution Xuanwei, China.  The findings from these studies 
suggest that upper airway gene-expression can reflect the host response to prolific 
sources of environmental exposures that are major risk factors for chronic lung disease.  
Lastly, I examine the cellular and physiologic consequences of electronic cigarette 
(ECIG) aerosol exposure by analyzing transcriptomic profiles of human bronchial 
epithelial cells that have either been (1) differentiated and exposed in vitro or (2) acquired 
via bronchoscopy from the airway epithelium of ECIG users.  
The studies detailed in this dissertation offer valuable insight that will accelerate 
the efforts to evaluate the health effects of both well-established and emerging types of 
inhaled exposures in large-scale population studies.  Furthermore, the transcriptomic 
strategies woven throughout the following chapters push for a novel assessment paradigm 
that may enable the public health community to rapidly characterize the physiologic host 
response to inhalation exposures of different sources, and to evaluate the biologic 
consequences of exposure-reduction initiatives.  	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CHAPTER ONE:   
INTRODUCTION 
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1.1 The Transcriptome 
Over the past two decades, an ever-burgeoning arsenal of –omics approaches has 
flooded the toolboxes of scientists with an array of powerful high-throughput molecular 
techniques, the applications of which have been extremely valuable in painting a fuller 
portrait of human health and the biology of complex diseases. While such strategies span 
the gamut from genomics to proteomics and metabolomics, this body of work will focus 
on the application of transcriptomics, the study of total RNA in a cell or tissue1. An 
intermediate between genes and protein products, total transcript abundance is regarded 
as a molecular phenotype that provides a biologically relevant snapshot of cellular 
activity. Thus, characterization of the human transcriptome across a spectrum of chronic 
diseases has been instrumental for the identification of clinical subtypes in cancer2,3, 
development of diagnostic and prognostic markers4,5, and prioritization of drug targets6.  
 
1.2 The Exposome 
As the clinical utility of transcriptomics continues to broaden, there has been a 
major push to incorporate similar methods at the frontlines of exposure science. This 
initiative has recently garnered significant attention in part due to an emerging paradigm 
known as the “exposome”. In 2005, molecular epidemiologist Dr. Christopher Wild 
introduced the exposome as the totality of exposures (e.g. environmental, occupational, 
lifestyle) that is encountered throughout one’s lifetime, and the study of which 
precipitates the need to “develop methods with the same precision for an individual's 
environmental exposure as we have for the individual's genome”7.  
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The prospective value of assembling the exposome is extremely high, especially 
since elucidating source-exposure interactions and their associated mechanisms has the 
potential to generate novel approaches that can mitigate or even prevent adverse health 
outcomes8–10. However, a major challenge lies in identifying and implementing suitable 
methods that can effectively resolve complex external sources of exposures into biologic 
correlates of the body’s response to those insults. 
Traditional population-based exposure studies have primarily relied on indirect 
data collection strategies such as questionnaires. These can be burdensome to complete 
and susceptible to the inaccuracies that come with self-report11. Some of the ways in 
which modern field studies can now mitigate this issue is through the incorporation of 
personal and area monitoring (e.g. air samplers), as well as the collection of biologic 
specimens (e.g. saliva, urine). From this added layer of information, known toxicological 
and chemical markers of exposure can also be evaluated. Nevertheless, there is no 
unequivocal gold standard for leveraging these methods to accurately link external 
stressors to the biological responses that they elicit.  
More recently, the National Research Council expounded upon these limitations 
in report entitled Exposure Science in the 21st Century: a Vision and a Strategy12. This 
2012 summary emphasized that the integration of –omics technologies would be vital for 
achieving future milestones in the field of exposure science. The NRC has since also 
solicited involvement from multiple federal entities (e.g. EPA, NIEHS, and CDC) in 
order to accelerate trans-agency adoption of these efforts12. Now more than ever is the 
appropriate time to examine how high-throughput approaches such as transcriptomics can 
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facilitate advancements in human-based exposome research and related epidemiological 
studies. 
 
1.3 The Promise of Transcriptomics in Exposure Science 
The application of transcriptomics in this field is promising for a number of 
reasons. Similar to the human exposome, an individual’s transcriptome is highly dynamic 
and responsive to external stressors13. Importantly, the measurement of changes in 
transcript abundance can provide critical insight into the status of key biological 
mechanisms by which an exposure might be exerting its effects. Moreover, rather than 
reflect the total amount of exposure that comes into contact with host’s cells or target 
organ, gene-expression provides a proximal assessment of the host response to an 
exposure’s biologically effective dose (Figure 1).  
 
 
Figure 1. Transcriptomics in exposure science: changes in gene-expression capture the 
biological host response to inhaled emissions.  Adapted from Molecular Environmental 
Biology, Garte 199414.  
 
  Gene-expression changes are also thought to influence the molecular 
underpinnings of long-term structural and functional alterations within different target 
systems15. Furthermore, these gene-expression profiles can be derived to account for 
inter-individual variability in processes such as metabolism and repair16. Since the impact 
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of environmental exposures can be different for each individual due to a variety of 
genetic and non-genetic factors, this is vital for accurately relating exposures to health 
outcomes and disease risk17. Together, these advantages make the case that gene-
expression profiling can constructively mediate the interplay between external exposures 
and the physiologic host response.  
 
1.4 The Airway Field of Injury 
While a number of chemical compounds and environmental pollutants have been 
shown to alter the transcriptional profiles of model organisms, tobacco smoke is one of 
the few to have been examined through gene-expression profiling studies in human 
populations18. Several key findings in the space of cigarette use and lung health have 
begun to underscore the promise of transcriptomics in monitoring exposure-response 
relationships.  
Notably, it has been demonstrated that inhaled toxins from cigarette smoke 
creates genomic changes in exposed airway epithelial cells, and that gene-expression 
profiles from these histologically normal cells can be developed to reflect the host 
response to that exposure19. Additionally, this profiling approach has been used to 
examine the molecular changes incurred upon exposure reduction. For instance, upon 
smoking cessation a subset of genes in former smokers will revert to baseline levels of 
expression similar to those found in nonsmokers, while another subset of genes will 
remain activated even decades thereafter20.  Leveraging this “field of injury” concept, 
researchers have further shown that gene-expression differences in the normal airway 
epithelium of smokers can serve as a sensitive and specific indicator of lung cancer risk4, 
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as well as a guide for the clinical management of  Chronic Obstructive Pulmonary 
Disease (COPD)21.  
Of particular relevance to this thesis, related gene-expression studies have 
pinpointed concordant smoking-induced changes in epithelial cells from the bronchial 
epithelium and those obtained non-invasively from the buccal and nasal epithelium22,23. 
This suggests that the relatively accessible epithelial cell lining of the nose and mouth 
may provide additional opportunities to examine the host response to complex inhaled 
exposures.   
  
1.5 Oligonucleotide Probe Microarrays 
The subsequent chapters feature three major studies that primarily assess the 
human response to different inhaled exposures. In order to examine transcriptional 
profiles of the human intra- and extra-thoracic airway epithelium, these analyses relied on 
high-throughput oligonucleotide microarray technology. Importantly, all three studies 
outlined in the Dissertation Aims section use the same generation of Affymetrix Human 
Gene ST 1.0 arrays24–27. These GeneChipsTM are constructed using a stepwise 
photolithographic process, where light directs the in situ synthesis of approximately 
700,000 probes (25-mer oligonucleotides) along a glass slide. This array relies on 
multiple probe sets, where each set targets the length of single transcript. In addition to 
having probes that can interrogate the expression of well-annotated genes, there are also 
approximately 20,000 background probes to allow for background estimation. 
Microarrays are therefore inherently limited to measuring the abundance of known 
transcripts28; the arrays used in the subsequent analyses contain approximately 19,700 
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gene-level probe sets that have full-length transcript annotations as provided by the 
NCBI29. While next-generation sequencing technologies circumvent this limitation, they 
were not incorporated into the conception and design of the following studies. However, 
as the methods surrounding RNA-seq become more standardized and cost-effective, use 
of this alternative approach warrants consideration in the execution of related future 
studies. 
 
1.6 Dissertation Aims 
The following aims seek to extend the field of injury hypothesis by using gene-
expression profiling and transcriptomic analyses to characterize the physiologic effects of 
inhaled pollutants on the human airway epithelium. These exposures include secondhand 
smoke and household air pollution – major environmental risk factors for chronic lung 
disease – in addition to electronic cigarette vapor, an emerging public health concern with 
vastly unknown health consequences. Collectively, these investigations will highlight 
transcriptomics as a novel exposure assessment paradigm in characterizing human-
exposed populations, provide insight into molecular pathways and changes associated 
with these exposures, and concomitantly illuminate a sliver of the airway epithelium’s 
exposome.  
 
Aim 1: Use the nasal epithelial transcriptome to capture the physiologic response to 
secondhand smoke or environmental tobacco smoke (ETS) exposure.  
While active tobacco use remains the leading preventable cause of death in the 
United States, passive exposure to cigarette smoke is also responsible for consistently 
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high incidences of morbidity and mortality. We have previously used airway gene-
expression profiles to gain insights to the human response to smoking. The purpose of 
this aim is to determine whether the airway can also reflect insults to ETS exposure. Here 
I examine the transcriptome of nasal epithelial cells obtained from independent cohorts of 
children and adults with and without passive exposure. Upon deriving gene-expression 
profiles associated with ETS, I further examine their biological implications as well as 
their concordance with signatures of active smoking. I also demonstrate the feasibility of 
using these profiles to predict ETS exposure status.  
 
Aim 2: Examine the effects of household air pollution from smoky coal combustion 
on the buccal epithelial transcriptome. 
 Household air pollution generated from the burning of solid fuels for heating and 
cooking is leading global health concern. Notably, this exposure is highly prevalent in 
rural counties of Yunnan Province, China where the elevated lung cancer risk in this 
population has been linked to the inhalation of combusted bituminous (smoky) coal. Thus 
far, there have been limited attempts to chart the landscape of molecular changes 
associated with human exposure to these emissions. Here I apply the airway field of 
injury paradigm to detect differences in the buccal epithelium of healthy nonsmoking 
women from rural Xuanwei, China who have been exposed to either smoky or smokeless 
coal emissions. After defining a gene-expression signature associated with smoky coal 
exposure, I subsequently characterize its functional implications and lend mechanistic 
insight to prior epidemiological studies that have examined disease risk within this sub-
population.  
	  	   9 
 
Aim 3: Identify cellular and physiologic responses to electronic cigarette (ECIG) 
exposure using transcriptome profiling of airway epithelial cells exposed in vitro and 
in vivo.  
The recent emergence of electronic cigarettes and their rapidly growing user base 
has been accompanied by evolving public health and regulatory considerations. In 
particular, the FDA recognizes that additional studies are currently needed to evaluate the 
potential risks of ECIGs when they are used as intended. In order to interrogate the 
cellular effects of ECIG exposure, I first examine gene-expression changes in primary 
human bronchial epithelial cells that have been differentiated in an air liquid interface 
and subsequently exposed to traditional tobacco smoke or ECIG aerosols in vitro. Next, I 
capture physiologic effects of ECIG exposure by profiling bronchial airway cells 
obtained from former smokers and former smokers who have transitioned to ECIGs. 
These results highlight our ability to use transcriptomics to characterize and evaluate the 
biologic consequences of alternative tobacco products. 
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2.1 Introduction  	  
Tobacco smoke is a complex aerosol of over 4,000 compounds including at least 
60 established carcinogens30,31. In 1964, the U.S. Surgeon General's Advisory Committee 
on Smoking and Health released a multidisciplinary evaluation of tobacco use and its 
deleterious effects on human health32. This landmark report highlighted cigarette 
smoking as a major risk factor for cardiovascular disease and chronic lung diseases, 
spurring the implementation of key tobacco control initiatives. The prevalence rate of 
cigarette smoking over the past fifty years has since dramatically decreased from 43% in 
1965 to the current rate of 18%33. Despite this substantial decline, tobacco use remains 
the leading preventable cause of death in the United States.  
The harmful effects of cigarette smoke exposure are not limited to smokers. 
Secondhand smoke (SHS) or environmental tobacco smoke (ETS) exposure claims the 
lives of nearly 42,000 nonsmoking Americans each year34. ETS is a combination of side-
stream smoke expelled from the burning end of a tobacco product and mainstream smoke 
exhaled by an active user35. This involuntary exposure is a renowned cause of severe 
health conditions including lung cancer, heart disease, and acute respiratory effects36.  
Children who live with smokers are among the most vulnerable to the hazards of 
ETS.  Compared to adults, they possess significantly less control over the air quality 
present within their indoor environments37. Physiologically, also exhibit notably higher 
rates of metabolism and inhale greater volumes of air per unit of body weight38,39. 
Children with ETS exposure are at an elevated risk of developing acute respiratory 
infections, exacerbated asthma symptoms, and impaired lung growth40.  
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Questionnaires are classically employed in tobacco and health-related population-
based studies in order to characterize active smoking behavior and ETS exposure. They 
are generally accurate indicators of smoking status, though reporting biases have been 
noted to arise particularly in studies that include pregnant women, infants, and 
individuals who are enrolled in clinical cessation studies41–43. There appears to be 
minimal discrepancy between exposure results obtained from paper-based or online 
questionnaires compared to in-person structured interviews44–46. However, estimates of 
exposure intensity including the number of cigarettes smoked per day, time since quit, 
and cumulative exposure to ETS are less accurately captured through self-report47.  
Human biomonitoring is a valuable complementary approach for quantitating the 
intake of tobacco smoke. Cotinine, a biological metabolite of nicotine, is commonly 
assayed for the determination of tobacco use48. In comparison to nicotine’s half-life of 2-
3 hours, cotinine has a longer half-life of 18-20 hours in adults and 32-38 hours in 
children49,50. Urine, serum, and saliva cotinine are all capable of distinguishing active 
smokers from nonsmokers including passive smokers51,52. However, low levels of active 
smoking can introduce discrepancies between self-report and anticipated cotinine 
levels53,54. This issue is amplified in the context of ETS studies, which have shown that 
passively exposed subjects and light active smokers can exhibit overlapping cotinine 
levels55–58 . Wide distributions of cotinine are also consistently detected in ETS-exposed 
and unexposed children59,60. Thus similar to other metabolites, cotinine is susceptible to 
inter-individual variability in metabolism and excretion61.  
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Environmental sampling is another useful adjunct to questionnaires and 
biomonitoring in estimating the extent of ETS exposure. For instance, airborne nicotine 
and particulate matter (PM) represent two commonly assessed gas and solid phase 
components that are correlated with environmental levels of ETS constituents62. These 
measurements require the use of either active or passive sampling devices. The former 
traditionally incorporates a pump that actively draws air into a filter or adsorbent tube, 
while the latter relies on diffusion to a collection surface63. Although airborne nicotine is 
specific to tobacco combustion, it has a tendency for desorption and to be re-emitted even 
in the absence of active smoking50. One major limitation of PM is its ubiquitous nature as 
an environmental pollutant. Therefore at low concentrations of ETS, it can be especially 
difficult to distinguish tobacco smoke PM from other sources of air pollution64. 
  The drawbacks of available exposure assessment methodologies collectively 
underscore that no single marker precisely captures the degree of a nonsmoker’s ETS 
exposure or fully reflects the downstream health consequences that the exposure may 
render upon an individual. Even the integration of classical markers provides a paucity of 
information regarding the human biologic response to ETS exposure. In contrast, 
genomic profiles of the airway epithelium have offered unique insight into the functional 
pathways that are triggered in response to smoking19,20,65. Furthermore, these expression 
signatures have been demonstrated to serve as accurate predictors of lung disease risk in 
current and former smokers4,21.  
It remains to be seen, however, whether the transcriptome of the extra-thoracic 
airway epithelium of nonsmokers can capture the human response to ETS pollution. The 
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following study therefore explores how the field of injury phenomenon can be extended 
to evaluate nasal gene-expression as an indicator of the physiologic host response to 
variable levels of ETS exposure in children and adults.  
 
2.2 Results  
2.2.1 Study Population 	  
Nasal epithelial samples were collected from independent cohorts of children and 
adults with and without ETS exposure (Figure 2.1). At Boston University, samples from 
52 adults pertaining to three arms of exposure were successfully processed for 
downstream analysis (n=13 active smokers; 20 ETS-exposed; 19 unexposed). Similarly, 
we analyzed the gene-expression profiles of 76 children with and without household ETS 
exposure (n=36 ETS-exposed; 40 unexposed). These brushings were obtained from field 
teams assembled at Columbia University and Johns Hopkins University. The same 
sample collection protocol was implemented across all sites, and we observed no 
differences in the quality of RNA isolated. The corresponding demographic information 
for all subjects is summarized in Table 2.1.  
While the exposure patterns of all subjects profiled were determined through self-
report and questionnaire, these responses corroborated with available serum and saliva 
cotinine concentrations. Specifically, the adult serum cotinine concentrations were 
resolved into three bins that corresponded with the three exposure arms (active smokers, 
ETS-exposed, unexposed). Although saliva cotinine concentrations between ETS-
exposed and unexposed children were significantly different, they not resolve into 
discrete bins.  
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In addition to having their cotinine levels profiled, a subset of the children had 
corresponding objective measures of exposure obtained from weeklong personal (p) and 
home/stationary (h) area sampling devices. These metrics include particulate matter ≤ 2.5 
µm (PM2.5), UV light absorbing particulate matter (UVPM), black carbon (BC) and 
airborne nicotine. Interestingly, the measurements retrieved from both home and personal 
area samplers were highly correlated. Airborne nicotine, UVPM and cotinine levels were 
the most highly correlated air sampling indicators of ETS exposure (Figure 2.2).  
2.2.2 Nasal Gene-Expression Profiles Associated with Active Smoking 	  	   By comparing the profiles of current smokers (n=13) and unexposed (n=19) 
adults, we first demonstrated the presence of a robust gene-expression signal for active 
smoking in the nasal epithelium (Figure 2.3A). The functional categories for which these 
genes were enriched were consistent with what has been previously documented as 
altered throughout the intra- and extra-thoracic airway of current smokers20,22 including 
the metabolism of xenobiotics by Cytochrome P450 and the activation of neuroactive 
ligand receptor signaling (Figure 2.3B). The recapitulation of these results affirmed the 
quality of our gene-expression data, and provided a basis of comparison for our 
subsequent analyses.   
2.2.3 ETS-Associated Profiles in the Nasal Epithelium of Adults 	  
We then compared the expression profiles of the ETS-exposed (n=20) adults to 
those of the same unexposed adults (n=19) who were incorporated in our prior active 
smoking analysis. Through the application of linear modeling, we identified 325 genes 
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(p<0.005) associated with ETS exposure (Figure 2.4A). The functional enrichment of 
these transcriptomic changes is detailed in Table 2.2. As previously noted, the relative 
serum cotinine levels in the ETS exposed adults were markedly lower than the resulting 
levels from mainstream smoke uptake within the group of active smokers. Through our 
GSEA analysis, however, we observed that that the up-regulated and down-regulated 
components of these ETS-associated gene-expression changes were concordant with the 
transcriptomic changes present in the nasal epithelium of the active smokers (Figure 
2.4B).  
2.2.4 ETS-Associated Profiles in the Nasal Epithelium of Children 	  
As demonstrated through their corresponding cotinine and air sampling 
measurements, the 76 children profiled exhibited a wide range of exposure levels. 
Ultimately, the gene-expression changes within the nasal epithelium of ETS-exposed 
(n=36) and unexposed (n=40) children were most appropriately modeled through 
Surrogate Variable Analysis (SVA). This proved effective in adjusting for sources of 
technical and biological variation that could not be accounted for by employing the same 
linear modeling approaches used to assess the adult expression profiles. Upon correcting 
for 9 surrogate variables, we detected 272 genes (p<0.005) associated with ETS exposure 
across the children (Figure 2.5). In order to evaluate how the biological processes 
enriched for ETS exposure in children compared to those activated in the independent 
cohort of exposed adults, we performed GSEA with the same set of gene ontologies used 
to examine the transcriptomic landscape of ETS-exposed adults. Of note, the nasal gene-
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expression changes activated among the ETS-exposed children were highly enriched for 
a number of metabolic and catabolic processes (Table 2.3). 
2.2.5 Concordance of ETS Profiles Between Children and Adults 
We further investigated how our independently derived signatures of ETS behave 
with respect to one another as well as in relation to a previously generated signature of 
active smoking in the bronchial airway. Interestingly, we found that the 325 genes 
modulated in adults with ETS exposure was concordantly changed within the nasal 
epithelial transcriptome of ETS-exposed children (Figure 2.6).  We also observed that a 
subset of gene-expression changes that occur in the bronchial airway of active smokers20 
are similarly changed in both adults and children exposed to ETS (Figure 2.7). This 
suggests that similar to what is observed throughout the airway epithelium of active 
smokers, the inhalation of ETS induces a transcriptomic response that is shared across the 
respiratory tract. 
2.2.6 Nasal Gene-Expression as a Biomarker of Tobacco Exposure 	  
Having identified gene-expression signals associated with active tobacco use and 
ETS exposure in the nasal epithelium, we were interested to determine the feasibility of 
using gene-expression profiles to discriminate active or passively exposed individuals 
from those with no reported exposure. Using an adapted version of an in-house biomarker 
pipeline originally developed by Dr. Joshua Campbell of the Spira-Lenburg Lab, we 
evaluated the performance of biomarkers in 100-fold cross validation using splits of the 
gene expression data (80% training, 20% test). This was first done considering active 
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smokers versus unexposed subjects, and again for ETS-exposed subjects versus 
unexposed subjects (Figure 2.8). As expected, the gene-expression data from the adult 
cohort was more robust at classifying active smokers than passive smokers. For the active 
smoking biomarkers, the average AUC was 0.73, with the most optimal parameters 
yielding a test AUC of 0.89. For ETS exposure, the average AUC was 0.69, with the 
most optimal set of parameters yielding a test AUC of 0.78 (Table 2.4). These results 
suggest that biomarkers built upon nasal gene-expression exhibit a robust capability for 
predicting exposure status to tobacco smoke, be it in the form of active smoking or 
passive exposure. 
 
2.3 Methods  	  
Subject Recruitment 
 
At Boston University Medical Center (BUMC), healthy 20-30 year old subjects 
were recruited into one of three arms based on their exposure to tobacco smoke: (1) 
active current smokers, (2) never smokers exposed to ETS from a member of the 
household, or  (3) unexposed subjects. The three groups were balanced for gender and 
race in order to control for potential covariate effects on smoking-associated gene-
expression changes. Subjects recruited at BUMC were designated as a passive smoker if 
they lived with a current smoker who smoked at least two cigarettes-per-day for at least 
six months in the same household, while unexposed subjects were never smokers with no 
known degree of ETS exposure.  
Nasal epithelial cell collection was similarly implemented at Columbia University 
and Johns Hopkins University, where enrolled subjects included children who were 
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classified as either: (1) passively exposed to household ETS or (2) unexposed. For the 
children, weeklong area sampling was also employed through the use of single-channel 
micro personal exposure monitors (RTI International, Research Triangle Park, NC) and 
stationary in-home monitors. Plasma cotinine concentrations among BUMC subjects 
were assessed using liquid chromatography - tandem mass spectrometry (LC-MS/MS)66. 
Enzyme-Linked Immunosorbent Assays (ELISAs) were used to assess cotinine 
concentrations in the saliva samples obtained from the child cohort.  The Institutional 
Review Boards of each involved institution approved these studies, and all enrolled 
human subjects provided informed written consent. 
 Figure 2.1. Overview of subject recruitment for ETS study. 
Nasal Epithelial Cell Collection 
 
Nasal airway epithelial cells were collected by brushing the inferior turbinate as 
previously described23, with the omission of lidocaine. Briefly, a nasal speculum 
(Bionox, Toledo, OH) was used to spread the left or right nare as a standard cytology 
brush (Cytosoft Brush, Medical Packaging Corporation, Camarillo CA) was inserted 
beneath the inferior nasal turbinate. Brushes were rotated once, removed, and 
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subsequently placed in 1mL of RNAprotect Cell Reagent (Qiagen). The samples were 
stored at -80° Celsius. All samples were shipped to BU for RNA isolation, where 
miRNeasy Mini and RNeasy MinElute Cleanup kits were used per the manufacturer’s 
protocol after the samples were thawed. RNA Integrity was confirmed on an Agilent 
2100 Bioanalyzer using the RNA 6000 Pico Kit.   
 
Microarray Data Acquisition and Preprocessing 
 
1 ug of high molecular weight RNA was processed and hybridized to Affymetrix 
Human Gene 1.0 ST Arrays (Affymetrix, Santa Clara, CA). Probeset summarization, 
normalization, and generation of relative log2 gene expression levels were performed in R 
statistical environment (R 2-15.1) using the RMA algorithm in conjunction with the 
corresponding EntrezGene Chip Definition File67 (CDF v17.0). RLE, NUSE, and PCA 
metrics assessing all genes across all samples were used to assess microarray data quality. 	  
Differential Expression Analysis 
 
Since we have previously demonstrated that the response to active smoking elicits 
a strong gene-expression response throughout the airway, we were able to capture 
changes associated with active smoking in adults using a Student’s t test, where the False 
Discover Rate (FDR) for each gene was computed using Benjamini and Hochberg 
corrections68. The following linear regression models were then used to detect ETS-
associated gene-expression changes among the adults: 
Geneij = β0 + βage*Xage + βRIN*XRIN + εi     (1) 
Geneij = β0 + βage*Xage + βRIN*XRIN + βETS *XETS + εi   (2) 
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Geneij is the log2 expression for probeset i in subject j. The models controlled for the 
continuous variables of RIN and Age. The term εi   represents the random error (assumed 
to be normally distributed) and β0 represents the intercept. The full model in equation (2) 
contains the binary factor ETS, denoting whether the subject is passively exposed or 
unexposed. A gene's expression profile was considered associated with ETS if an 
ANOVA between the two models returned a significant p-value, indicating that model (2) 
is a better fit than model (1).  
Given that the sampling from children was implemented across cohorts at several 
sites, we anticipated that a large number of variables or sources of un-modeled variation 
would have an impact on the gene-expression results. Thus, Surrogate Variable 
Analysis69 (SVA) was employed in order to identify surrogate variables that might 
encompass unknown sources of biological or technical variation within the nasal gene-
expression data processed from the children. First, a residual expression matrix was 
generated upon removing any signal associated with the binary factor of ETS exposure. 
Next, the iteratively reweighted (IRW) analysis algorithm was used to identify subsets of 
genes that that contribute to remaining sources of heterogeneity in the residual matrix. A 
total of nine surrogate variables or primary sources of variation were identified in the 
residual matrix. To identify differentially expressed genes, the following reduced model 
(1) was compared to the full model (2):  
 
 Geneij = β0 + βSV1*XSV1 + βSv2*XSV2 + βSV3*XSV3 +βSV4*XSV4 + . . . +βSV9*XSV9   (1) 
 
 Geneij = β0 + βETS*XETS+ βSV1*XSV1 + βSv2*XSV2 + βSV3*XSV3 +βSV4*XSV4 + . . . +βSV9*XSV9  (2) 
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Here, Geneij is the log2 expression value of gene i, in subject j. ETS represents the binary 
factor denoting whether a subject was either passively exposed or unexposed, while terms 
SV1..SV9 represent the surrogate variables identified from the SVA analysis.  
 
Functional Enrichment and Concordance Across Datasets 
Gene Set enrichment Analysis (GSEA)70 was used to conduct functional 
enrichment of the transcriptomic changes associated with active and ETS exposure in 
children and adults. The results from our differential expression analyses were used to 
generate gene sets, and the t statistics generated from each of those approaches were used 
to compile ranked lists. This allowed for the examination of gene set behavior across 
independently generated datasets.  
 
Biomarker Development for Active Smoke and ETS Exposure 
 Using a modified in-house pipeline originally constructed by Dr. Joshua 
Campbell71, combinations of the following parameters were used to generate 648 
biomarkers per phenotype: 
 Parameter One – Feature Filtering (4 options): Genes or “features” were ranked 
according to their median absolute deviation. The top 100% (all), 75%, 50%, and 25% 
features were subsequently filtered. 
 Parameter Two – Feature Selection (3 options): Linear modeling (limma package) 
whereupon features were ranked by t statistic; Glmnet (glmnet_1.7.1 package) with the 
alpha parameter set to 0.5; Random Forest (randomForest_4.6-2 package) whereupon 
features were ranked by variable importance criteria. 
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 Parameter Three – Number of Features (9 options): Biomarker sizes (N) of 50, 60, 
70, 80, 90, 100, 110, 120, and 130 were considered. The ways in which these sizes were 
selected varied depending on Parameter Two. Briefly, for the Linear modeling feature 
selection method, the N/2 most up-regulated down-regulated genes were selected based 
on positive and negative t statistics, respectively. For the Glmnet feature selection 
method, the N features with non-zero coefficients were selected, though this also 
depended on the stepwise decrease of the lambda parameter. For Random Forest feature 
selection method, the top N ranked features were selected.  
 Parameter Four – Classifier (6 options): Weighted Voting; k-Nearest-Neighbors 
(class_7.3-3 package); Support Vector Machine; Random Forest (randomForest_4.6_2 
package); NaïveBayes (e1071_1.6 package); and Glmnet (glmnet_1.7.1 package) where 
parameters were implemented as previously described71. 
These biomarkers were evaluated in 100-fold cross-validation, wherein random 
80-20 splits of the adult nasal gene-expression data was used to obtain training and 
testing performance measures, respectively. This biomarker approach was first applied to 
Active Smokers (n=13) and Unexposed adults (n=19) to identify biomarker performance 
metrics in distinguishing active tobacco smoke exposure. It was subsequently applied to 
ETS-exposed adults (n=20) and Unexposed adults (n=19) to identify biomarker 
performance metrics in distinguishing passive tobacco smoke exposure.   
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Table 2.1. Overview of children and adults profiled for ETS study.  
 
Mean ± SD; Median (IQR); *Statistically significant between exposed and unexposed groups 
(p<0.05) as calculated by Student’s t Test or Wilcoxon-Mann-Whitney Test. Weeklong averages 
of household living area (h) and personal area (p) sampling measurements were obtained for 
particulate matter with a diameter of less than 2.5um (PM2.5), ultraviolet light-absorbing 
particulate matter (UVPM), black carbon (BC), and airborne nicotine (processed for 59 subjects). 
 
 
 
 
 
 
 
 
 
 
Children (n=76) Adults (n=52) 
SHS Exposed 
n=36 
Unexposed 
n=40 
Active Smoker 
n=13 
SHS Exposed 
n=20 
Unexposed 
n=19 
Gender 11M / 25F 18M / 22F 5M / 8F 9M / 11F 4M / 15F 
Age 11 ± 3 11 ± 2 25 ± 4 23 ± 3  22 ± 3  
RIN 7.1 ± 1.2 6.9 ± 1.4 6.2 ± 1.4 7.1 ±  1.8 7.3 ± 1.4 
Serum Cotinine* 
(ng/ml) -- -- 204.9 (166.2) 0.283 (0.668) 0.001 (0.038) 
Saliva Cotinine* 
(ng/ml) 0.80 (3.11) 0.28 (0.91)  -- -- -- 
PM2.5 (p) (ug/m3) 14.25 (2.59) 13.50 (0.93)  -- -- -- 
PM2.5 (h)*(ug/m3) 16.90 (12.85)  14.10 (7.20)  -- -- -- 
UVPM (p)* (ug/m3) 0.64 (2.59)  0.40 (0.93)  -- -- -- 
UVPM (h)* (ug/m3) 0.66 (1.38)  0.08 (0.41)  -- -- -- 
BC (p) (ug/m3) 0.95 (0.80)  0.87 (0.66)  -- -- -- 
BC (h) (ug/m3) 1.16 (0.78) 0.97 (0.45) -- -- -- 
Nicotine (ug/m3 ) 0.06 (0.69)  0.02 (0.03)  -- -- -- 
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Table 2.2. Functional enrichment of genes modulated in adults with ETS exposure. GSEA 
results of biological processes significantly enriched in genes up-regulated with ETS exposure in 
adults (q<0.25). NES: Normalized Enrichment Score. 
 
Gene$Set:$GO$Biological$Process NES p6val q6val
GOLGI_VESICLE_TRANSPORT 2.3 <0.001 0.005
MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS 2.17 <0.001 0.006
PEROXISOME_ORGANIZATION_AND_BIOGENESIS 2.03 <0.001 0.032
TRANSLATION 1.96 <0.001 0.050
TRANSLATIONAL_INITIATION 1.93 <0.001 0.059
RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS_AND_ASSEMBLY 1.91 <0.001 0.060
CELLULAR_BIOSYNTHETIC_PROCESS 1.87 <0.001 0.071
REGULATION_OF_TRANSLATIONAL_INITIATION 1.86 <0.001 0.067
RESPONSE_TO_OXIDATIVE_STRESS 1.85 <0.001 0.068
SECRETORY_PATHWAY 1.81 <0.001 0.080
BIOSYNTHETIC_PROCESS 1.79 <0.001 0.086
MACROMOLECULE_BIOSYNTHETIC_PROCESS 1.77 <0.001 0.095
COFACTOR_METABOLIC_PROCESS 1.77 <0.001 0.090
PROTEIN_RNA_COMPLEX_ASSEMBLY 1.75 <0.001 0.094
I_KAPPAB_KINASE_NF_KAPPAB_CASCADE 1.68 <0.001 0.107
PROTEIN_FOLDING 1.67 <0.001 0.106
INTRACELLULAR_TRANSPORT 1.67 <0.001 0.103
SECRETION_BY_CELL 1.66 <0.001 0.102
RNA_PROCESSING 1.65 <0.001 0.099
RNA_SPLICING 1.65 <0.001 0.097
REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE 1.6 <0.001 0.122
AMINO_ACID_METABOLIC_PROCESS 1.51 <0.001 0.157
NEGATIVE_REGULATION_OF_APOPTOSIS 1.5 <0.001 0.162
NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH 1.49 <0.001 0.167
ORGANIC_ACID_METABOLIC_PROCESS 1.47 <0.001 0.181
ESTABLISHMENT_OF_CELLULAR_LOCALIZATION 1.45 <0.001 0.194
PROTEIN_TRANSPORT 1.43 <0.001 0.196
CELLULAR_LOCALIZATION 1.41 <0.001 0.208
ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT 2.19 0.003 0.008
COFACTOR_BIOSYNTHETIC_PROCESS 1.91 0.003 0.053
PHOSPHOINOSITIDE_BIOSYNTHETIC_PROCESS 1.83 0.003 0.072
PROTEIN_AMINO_ACID_N_LINKED_GLYCOSYLATION 1.71 0.003 0.103
COENZYME_METABOLIC_PROCESS 1.72 0.004 0.108
POSITIVE_REGULATION_OF_I_KAPPAB_KINASE_NF_KAPPAB_CASCADE 1.65 0.005 0.099
MRNA_PROCESSING_GO_0006397 1.57 0.005 0.131
DOUBLE_STRAND_BREAK_REPAIR 1.72 0.006 0.105
UBIQUITIN_CYCLE 1.62 0.008 0.118
PROTEIN_AMINO_ACID_LIPIDATION 1.7 0.009 0.108
TRNA_METABOLIC_PROCESS 1.7 0.009 0.106
MITOCHONDRIAL_TRANSPORT 1.68 0.009 0.113
NUCLEOBASENUCLEOSIDE_AND_NUCLEOTIDE_METABOLIC_PROCESS 1.58 0.010 0.127
RIBOSOME_BIOGENESIS_AND_ASSEMBLY 1.73 0.011 0.104
POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION 1.45 0.013 0.190
MRNA_METABOLIC_PROCESS 1.44 0.014 0.199
NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION_AND_BIOGENESIS 1.61 0.016 0.117
PHOSPHOINOSITIDE_METABOLIC_PROCESS 1.56 0.017 0.138
CARBOXYLIC_ACID_METABOLIC_PROCESS 1.45 0.017 0.198
GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS 1.58 0.018 0.128
RESPONSE_TO_TEMPERATURE_STIMULUS 1.68 0.019 0.110
GLYCOPROTEIN_METABOLIC_PROCESS 1.4 0.019 0.217
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Table 2.3 Functional enrichment of genes modulated in children with ETS exposure. GSEA 
results of biological processes significantly enriched in genes up-regulated with ETS exposure in 
children (q<0.25). NES: Normalized Enrichment Score.  
 
Gene$Set:$GO$Biological$Process NES p6val q6val
CELLULAR_BIOSYNTHETIC_PROCESS 2.00 <0.001 0.045
POSITIVE_REGULATION_OF_CASPASE_ACTIVITY 1.98 <0.001 0.039
BIOSYNTHETIC_PROCESS 1.92 <0.001 0.056
CASPASE_ACTIVATION 1.92 <0.001 0.049
NITROGEN_COMPOUND_CATABOLIC_PROCESS 1.90 <0.001 0.052
AMINO_ACID_AND_DERIVATIVE_METABOLIC_PROCESS 1.87 <0.001 0.062
MACROMOLECULE_BIOSYNTHETIC_PROCESS 1.87 <0.001 0.055
GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY 1.84 <0.001 0.063
APOPTOTIC_PROGRAM 1.74 <0.001 0.100
GOLGI_VESICLE_TRANSPORT 1.67 <0.001 0.121
CATABOLIC_PROCESS 1.66 <0.001 0.122
ORGANIC_ACID_METABOLIC_PROCESS 1.66 <0.001 0.119
CELLULAR_CATABOLIC_PROCESS 1.66 <0.001 0.117
AMINE_METABOLIC_PROCESS 1.63 <0.001 0.126
RESPONSE_TO_BIOTIC_STIMULUS 1.62 <0.001 0.122
RESPONSE_TO_CHEMICAL_STIMULUS 1.60 <0.001 0.138
INTRACELLULAR_TRANSPORT 1.56 <0.001 0.156
ONE_CARBON_COMPOUND_METABOLIC_PROCESS 2.03 0.002 0.041
RESPONSE_TO_HORMONE_STIMULUS 1.83 0.002 0.059
ELECTRON_TRANSPORT_GO_0006118 1.82 0.002 0.060
POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY 1.82 0.002 0.060
NITROGEN_COMPOUND_METABOLIC_PROCESS 1.75 0.002 0.106
AMINO_ACID_METABOLIC_PROCESS 1.68 0.002 0.121
REGULATION_OF_HYDROLASE_ACTIVITY 1.65 0.002 0.120
CARBOXYLIC_ACID_METABOLIC_PROCESS 1.56 0.002 0.155
LIPID_TRANSPORT 1.71 0.004 0.123
CHROMATIN_MODIFICATION 1.70 0.004 0.120
NEURITE_DEVELOPMENT 1.66 0.004 0.116
NEURON_APOPTOSIS 1.76 0.006 0.097
HISTONE_MODIFICATION 1.69 0.006 0.124
GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS 1.69 0.006 0.119
RESPONSE_TO_ORGANIC_SUBSTANCE 1.67 0.006 0.122
NEUROGENESIS 1.58 0.006 0.139
COVALENT_CHROMATIN_MODIFICATION 1.70 0.008 0.122
PROTEIN_FOLDING 1.60 0.008 0.135
RESPONSE_TO_OXIDATIVE_STRESS 1.64 0.010 0.125
NEURON_DEVELOPMENT 1.59 0.010 0.143
CELLULAR_RESPONSE_TO_STIMULUS 1.72 0.012 0.118
GLYCOPROTEIN_BIOSYNTHETIC_PROCESS 1.58 0.015 0.145
AMINE_CATABOLIC_PROCESS 1.68 0.016 0.122
ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT 1.64 0.017 0.122
RESPONSE_TO_DRUG 1.63 0.017 0.123
AXONOGENESIS 1.56 0.018 0.159
EPIDERMIS_DEVELOPMENT 1.54 0.021 0.162
TRANSLATIONAL_INITIATION 1.56 0.022 0.155
REGULATION_OF_MITOTIC_CELL_CYCLE 1.63 0.024 0.128
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Table 2.4 Performance of optimal active smoking and ETS nasal gene-expression 
biomarkers derived from 100-fold cross-validations.   
(A) Optimal smoking and ETS biomarker parameters based on test Area Under the Curve (AUC) 
values derived from 100-fold cross-validation of 648 biomarkers.  
 
 
 
 
(B) Average test performance of the corresponding biomarkers based on 100-fold internal cross-
validation. Metrics include Accuracy, Sensitivity, Specificity, Positive Predictive Value (PPV), 
Negative Predictive Value (NPV), Matthew’s Correlation Coefficient (MCC) and Area Under the 
Curve (AUC). 
 
 
 
 
 
 
 
 
 
Biomarker Feature Filter (MAD) Feature Selection Feature Size Classifier
Active Smoking 100% Linear Modeling N=50 Glmnet
ETS Exposure 25% Glmnet N=60 Glmnet
Biomarker Accuracy Sensitivity Specificity PPV NPV MCC AUC
Active Smoking 0.79 0.61 0.91 0.86 0.80 0.55 0.89
ETS Exposure 0.68 0.68 0.67 0.76 0.63 0.37 0.78
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Figure 2.2. Correlation of personal and stationary exposure metrics.  
Spearman’s rank correlations were calculated between each available exposure metric, including 
those obtained from personal (p) and stationary home (h) sampling devices. Red and blue 
intensities correspond to the positive or negative value of the correlation coefficient, respectively. 
The size of each circle scales with the absolute value of the correlation coefficient. Unsupervised 
hierarchical clustering was used to order the matrix and identify three major clusters outlined in 
bold. 
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Figure 2.3. Active smoking induces changes in the adult nasal epithelium.  
(A) Hierarchical clustering of 139 genes (p<0.005) which are differentially expressed between 
active smokers (Black; n=13) and unexposed adults (White; n=19), as identified using a Student’s 
t Test. The intensity of red and blue represents the relative up-regulation and down-regulation, 
respectively, of each gene. (B) Representative biological and molecular pathways for which the 
transcriptomic changes that occur with active tobacco exposure are enriched (GSEA FDR<0.05). 
Red and blue bars denote significantly modulated pathways containing up-regulated or down-
regulated genes, respectively.  
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Figure 2.4. ETS-associated gene-expression changes in the adult nasal epithelium. 
(A) Hierarchical clustering of 325 differentially expressed genes (p<0.005) between semi-
supervised ETS-exposed (Grey; n=20) and unexposed adults (White; n=19), as identified using a 
linear model adjusting for age and RIN. The intensity of red and blue represents the relative up-
regulation and down-regulation, respectively, of each gene. (B) GSEA results assessing the 
enrichment of the 325 genes with relation to the landscape of transcriptomic changes detected in 
active smokers (Figure 2.3) based on t statistics. Each vertical bar represents a single gene within 
a gene set and its occurrence among the ranked list. Lines highlighted in blue and red represent 
genes that contribute to the core enrichment of the down-regulated and up-regulated gene sets, 
respectively. The color bar indicates the strength of association that gene-expression has with 
ETS-exposure as ranked by the t-statistics generated from the analysis of actively exposed versus 
unexposed adults.  
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Figure 2.5. Signal for ETS exposure in the nasal epithelium of children.  
Hierarchical clustering of 272 genes that are differentially expressed between ETS-exposed 
(Grey; n=36) and unexposed (White; n=40) children (p<0.005). The following genes were 
detected using SVA, whereupon the residual matrix adjusting for the detected surrogate variables 
was used to plot the genes. 
 
 
 
 
 
 
 
 
 
Figure 2.6. Concordance of passive exposure signals in children and adults.  
ETS-associated transcriptomic changes detected in the child cohort behave concordantly in the 
nasal epithelium of adults. The 325 genes that were differentially expressed between ETS-
exposed and unexposed adults were examined in the context of ranked transcriptomic changes in 
children. Each vertical bar represents a single gene within a gene set and its occurrence among 
the ranked list. Lines highlighted in blue and red represent genes that contribute to the core 
enrichment of the down-regulated and up-regulated gene sets, respectively. The color bar 
indicates the strength of association that gene-expression has with ETS-exposure as ranked by the 
t-statistics generated from the analysis of 76 children.  
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Figure 2.7. Genes activated in the bronchial airway of smokers are activated in subjects 
exposed to ETS. (A) Three leading edge heatmaps illustrate the behavior of 26 genes that are 
activated in the bronchial airway epithelium of smokers (n=21) versus never smokers (n=52)20 
and concordantly enriched in the nasal epithelium of ETS-exposed children and adults (GSEA 
FDR<0.05). (B) By applying PCA across the 26 genes, PC1 was extracted to reflect a composite 
score summarizing the behavior of these genes across each of the three datasets. *p<0.05 
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Figure 2.8. Nasal gene-expression as a biomarker for active and passive exposure.  
To test the feasibility of deriving a biomarker for exposure, 100-fold cross-validation of an 80% 
training to 20% test split was performed within the adult exposure cohort assembled at BUMC. 
Using a combination of 4 filtering parameters, 3 feature selection methods, 9 feature sizes, and 6 
feature selection methods, a pipeline was applied to assess the average test AUC across 648 
different biomarkers for the exposure group of interest. This was performed for  (A) current 
smokers versus unexposed adults and (B) passively exposed adults versus unexposed adults. For 
both investigations, 648 additional biomarkers were constructed from randomly generated 
datasets using shuffled exposure labels as a comparison. The most optimal models derived for 
active smoking and ETS exposure yielded a test AUC of 0.89 and 0.78, respectively.  
 
 	  	  	  	  	  	  	  	  	  	  	  
	  
	  	   34 
2.4 Discussion 
Prior work has shown that transcriptomic profiling of the bronchial, nasal, and 
buccal epithelium reveals unique physiologic and mechanistic insights regarding the 
human response to active cigarette smoking22. Here, we extend this field of injury 
concept to examine the airway’s ability to serve as a proximal indicator of the biologic 
response to inhaled household ETS. To our knowledge, this is the first time that gene-
expression profiling has been performed in healthy children and adults to demonstrate 
that passive exposure to cigarette smoke also induces a measurable transcriptomic 
response in the readily accessible nasal epithelium.   
Through coordinated multi-institutional efforts, we obtained nasal epithelial cells 
in concert with household ETS exposure information from independent cohorts of 76 
children and 52 adults. Each subject’s exposure status as an active smoker, non-smoker, 
or non-smoker exposed to ETS was based on self-report and questionnaire. Recognizing 
the value of using other markers to corroborate these data, we also acquired cotinine 
concentrations and environmental markers of ETS exposure. The challenges in using 
cotinine levels alone to determine ETS exposure are well documented, as several studies 
have consistently indicated relatively weak correlations between cotinine and self-
report72,73. Nevertheless, we observed that the cotinine distributions significantly differed 
across the different exposure arms of the children and adults profiled in our study.  
Among the adult active smokers profiled, we detected serum cotinine levels 
(median: 204.9 ng/mL) that were well above the proposed cut-off of 4 ng/mL as reported 
by Benowitcz et al. in 20084. This was in agreement with questionnaire results, which 
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indicate that these adults were long-term heavy smokers. We also observed significantly 
elevated serum cotinine levels among non-smoking adults with reported household ETS 
exposure (median: 0.283 ng/mL) as compared to our arm of unexposed adults. Together, 
85% of the non-smoking adults in our study had cotinine levels that were lower than the 
reported range of 0.5-15 ng/mL that has been previously detected in non-smokers with 
and without exposure to secondhand smoke74.  
Saliva cotinine concentrations between the exposed and unexposed arms of the 
profiled children were statistically significant but comparatively less pronounced; unlike 
the serum cotinine levels in adults, the saliva cotinine levels for a subset of the ETS-
exposed and unexposed children exhibited a degree of overlap. Specifically, 72% of the 
ETS-exposed children had cotinine levels that were within the 0-2 ng/mL range of 
cotinine levels detected among the unexposed children. This is consistent with the 
findings of Coultas et al. whose examination of over 1,300 individuals indicated that one-
third of non-smoking adults and children alike exhibited detectable cotinine levels despite 
not living with a smoker75.  Of note, the cotinine levels from the exposed children in our 
cohort were lower than those reported in Coultas’ 1987 study, where children of a 
comparable age range living with one smoker had a median salivary cotinine level of 2 
ng/mL. This may be the result of several factors including the implementation of tobacco 
control initiatives and heightened awareness of the deleterious effects of secondhand – all 
of which have become more prolific since the historic 1987 study took place. 
For these children, we also assessed several environmental markers of ETS as 
processed from weeklong personal and household area sampling filters. Consistent with 
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prior findings, the household concentration of respirable particles and nicotine appears to 
vary widely with reported indoor ETS exposure72,76. However, a number of the measures 
were concordant with measured cotinine levels. Specifically, we detected the highest 
degree of correlations between child saliva cotinine concentrations, household airborne 
nicotine levels, and UVPM levels. As expected, household and personal black carbon 
measurements were anti-correlated with all other measures with the exception of PM2.5.  
Similar to what we had noted in regards to cotinine levels, we observed concomitantly 
lower PM2.5 and airborne nicotine levels relative to what has been cited in other studies 
including a separate indoor air analysis of inner city children who lived with one 
household smoker77. Since we did not obtain household or personal air sampling metrics 
from the adults, it is unclear whether the higher cotinine levels within the children overall 
are due to higher levels of ETS. However, younger children have been shown to have 
higher cotinine concentrations than those of older children and adults, which may in part 
be due to physiologically slower rates of cotinine elimination78.  
While the cotinine and environmental indicators compiled suggest that the 
children and adults profiled in our study were exposed to relatively low levels of 
household ETS, our nasal gene-expression analysis detected a number of transcriptomic 
changes associated with ETS exposure. Among the adults, we observed the differential 
expression of 325 genes (p<0.005), more than three times what is expected by chance. 
This signature was concordant with the transcriptomic level of changes that were 
observed in the nasal epithelium of active smokers who were also profiled as a third arm 
of exposure in our study. The pathways for which these genes were enriched included the 
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metabolism xenobiotics by Cytochrome P450 (e.g. GSTM3, AKR1C1), glutathione 
metabolism, and oxidative phosphorylation. These biological responses are consistent 
with what is commonly activated throughout the airway epithelium of smokers as well as 
in epithelial cell responses to acute whole tobacco smoke exposure in vitro20,79–81.  
Within the children, we independently derived a separate signature of 272 genes 
(p<0.005) that was associated with household ETS exposure. Notably, the 325 genes that 
were either up- or down-regulated with exposure in the nasal epithelium of adults were 
significantly enriched in the same directions among exposed children. At the pathway 
level, the genes activated with exposure in children and adults were both representative of 
the response to oxidative stress. However, we observed a considerable number of 
metabolic and catabolic biologic processes uniquely enriched among the transcriptomic 
changes in the passively exposed children. This included biological processes such as 
nitrogen compound catabolism and amino acid metabolism, which are notably altered in 
developmental and reproductive toxicology studies82. Our findings are also consistent 
with reports that cigarette smoke exposure increases energy expenditure83,84. Notably, our 
functional analysis led us to identify the enrichment of the Human Phenotype Ontology85 
Death in Childhood (HP:0003819), the signal for which was attributed to elevated levels 
of gene-expression levels of of HMG-CoA lyase (HMGCL) and oxoglutarate 
dehydrogenase (OGDH). The continued investigation of these differences at a more 
detailed, functional level are required in order to determine whether they contribute to 
molecular underpinnings of disparate health outcomes that occur between ETS-exposed 
children and adults. 
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Furthermore, there appears to be a strong relationship between genes activated in 
nasal epithelium with response to ETS exposure and those that are activated throughout 
the airway in response to active smoking. Specifically, we identified 26 that are not only 
highly expressed in the bronchial airway of current smokers but also elevated among 
passively exposed children and adults. These genes included those of aldo-keto 
reductases and aldehyde dehydrogenases (ALDH3A1; AKR1C3; AKR1C2; ADH7), which 
are involved in the detoxification-oxidation of toxic aldehydes and tobacco 
carcinogens86,87. These results substantiate the hypothesis that secondhand smoke induces 
a field of injury effect.  
We are keenly interested in examining the repeatability of our findings beyond the 
limited cross-sectional scope of this study. Although we were able to validate our gene-
expression results across independent cohorts, it is of importance to implement 
longitudinal studies with repeated sampling in order to examine the stability of these 
gene-expression profiles across time. It is also of great interest for us to explore whether 
these profiles can reflect smoke-free interventions that are currently taking place across 
multiunit housing environments due to public health initiatives. Since gene-expression is 
dynamic and can reflect smoking cessation in active smokers, it is reasonable to 
hypothesize that these profiles would be sensitive indicators of exposure-intervention 
studies.  
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2.5 Conclusions  
The results from this study collectively indicate that similar to the effects of 
mainstream smoke, the exposure to indoor secondhand smoke induces a field of injury 
response that can be assessed through gene-expression profiling of the nasal epithelium. 
Moreover, we have demonstrated that ETS-associated transcriptomic changes are 
recapitulated across independent cohorts of children and adults. These patterns contribute 
an unprecedented amount of physiologically relevant information that other biological 
markers and exposure metrics such as cotinine levels and area sampling measurements 
are unable to provide. These findings promote the notion of an integrative exposure 
assessment approach that leverages high-throughput airway transcriptomics and other 
exposure monitoring techniques in large-scale human inhalation exposure studies in order 
to further elucidate mechanisms of ETS disease burden. It remains to be seen whether 
this relatively non-invasive technique may also yield substantial utility in studies that 
seek to assess the biologic consequences of ETS interventions. Finally, the observation 
that transcriptomic changes in the extra-thoracic airway can be used to monitor the 
response to secondhand smoke exposure hints at the potential of using this approach to 
examine the molecular implications of inhaled pollutants beyond just tobacco smoke. The 
implications of this will be explored in the subsequent chapter. 
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CHAPTER THREE:  
Transcriptomic Effects of Household Air Pollution 
in the Buccal Epithelium of Women from Xuanwei, China 	  
 
 
 	  	  	  	  	  	  	  	  	  	  	  
	  	   41 
3.1 Introduction 
Similar to tobacco smoke exposure, household air pollution (HAP) represents a 
chief environmental health concern. Approximately 3 billion people are exposed to HAP 
from the burning of coal and biomass globally88. This includes the use of charcoal, wood, 
animal dung and crop waste for cooking and heating. Exposure to HAP renders long-term 
health risks, including the development of cardiovascular and respiratory diseases 
including stroke, acute lower respiratory infections, chronic obstructive pulmonary 
disease (COPD), and lung cancer89–92. It is estimated that 4.3 million deaths in 2012 were 
attributable to solid fuel usage93.  
HAP is especially prominent in China, where half of the population currently 
relies on the incomplete combustion of solid fuels to meet basic energy needs94.	   In 
particular, the rural counties of Xuanwei and Fuyuan in Yunnan Province, China have 
served as a focal point in a number of large-scale epidemiological and exposure 
assessment studies95,96. This is perhaps due to the excessively high lung cancer rates 
documented throughout this region. These rates have been especially prominent among 
the nonsmoking female residents who commonly use unvented indoor firepits to burn 
coal and wood97–99. Previous investigations within this population have hypothesized that 
fuel subtype may be an important factor in characterizing lung cancer etiology, linking 
the high disease rates to the combustion of “smoky coal” (bituminous) as compared to 
“smokeless coal” (anthracite)95,97,100. More recently, studies have pinpointed differences 
in hydrocarbon composition as well as elemental and quartz content between the smoky 
and smokeless coals found in households across Xuanwei and Fuyuan101,102.  These 
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findings support the premise that smoky and smokeless coal exposure contributes to the 
observed heterogeneity in disease risk among this population. 
Although the classic epidemiological studies performed in Xuanwei and Fuyuan 
thus far have provided a wealth of insights regarding the consequences of HAP exposure, 
the mechanisms by which smoky and smokeless coal usage can lead to different health 
outcomes remain poorly understood. Just as we emphasized how airway gene-expression 
profiling can provide valuable insight in tobacco-related exposure studies, the application 
of high-throughput transcriptomics in HAP molecular epidemiology studies may help 
elucidate the biology behind the observed health effects.  
This chapter documents the profiling of the buccal epithelium of rural Chinese 
women with HAP exposure due to the burning of smoky and smokeless coal in order to 
characterize gene-expression changes that might offer insight to the physiologic response 
associated with the burning of smoky coal. From this analysis, we have derived a 
signature of genes in the buccal epithelium that are differentially expressed with smoky 
coal exposure. Importantly, we found the enrichment of a number of pro-inflammatory 
mediators among these differentially expressed genes as well as the significant 
enrichment of this gene-signature with that previously defined as changing within the 
upper and lower airway of tobacco smokers. These results shed new light on the 
molecular mechanisms associated with smoky coal exposure and may provide a 
biological basis for the increased risk of lung disease. 
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3.2 Results 
3.2.1 Study Population 
We generated HAP metrics and buccal gene-expression profiles from 35 subjects 
who are smoky coal (n=26) and smokeless coal (n=9) users (Figure 3.1; Table 3.1). 
Specifically, we obtained two-day averages of personal indoor PAH and PM2.5 
concentrations from healthy, nonsmoking females who reside in villages across Xuanwei 
and Fuyuan counties. Coal subtype was confirmed using geochemical analyses of the 
coal101. There were no significant differences in personal PM2.5 air concentrations 
between the two coal-user groups. Particle phase PAHs were detected at significantly 
higher levels for smoky coal users as compared to smokeless coal users, which is 
reflective of the larger study population from which these 35 subjects were derived102. 
Although none of the subjects were active tobacco users, all of them reported to have a 
history of passive smoke exposure. It is common for females in this region to abstain 
from smoking, while the males are predominantly smokers. 
3.2.2 Gene-Expression Changes Associated with Smoky Coal Exposure 
  Smoky and smokeless coal emissions are generally acknowledged as 
fundamentally different exposures due to differences in their carcinogenic composition 
and their differential association with lifetime risk of lung cancer97,99,103. We identified 
282 genes as differentially expressed (p<0.005) in the buccal epithelium of subjects 
exposed to smoky versus smokeless coal (Figure 3.2). This signature is comprised of two 
main gene clusters: lower expression in smoky coal-exposed subjects (Cluster One) and 
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higher expression in smoky coal-exposed subjects (Cluster Two), as compared levels 
found in smokeless coal users. Moreover, we found that including coal type in multiple 
linear regression models diminished the explanatory power associated with most PAHs 
(Table 3.2). Interestingly, our 282-gene signature also exhibited higher correlations with 
carcinogenic PAHs as compared to non-carcinogenic PAHs (Figure 3.3). In order to 
validate the differential behavior of the 282-gene signature, candidates exhibiting high 
differences in fold change (IL-8, CASP3) were selected for RT-PCR within an 
independent set of buccal samples from smoky (n=3) and smokeless (n=3) coal users 
(Figure 3.4). 
3.2.3 Biological Enrichment and Pathway Analysis 
We conducted functional enrichment analysis on each of the two main gene 
clusters (Table 3.3). The top biological categories enriched in Cluster One (lower in 
smoky coal users) include regulatory processes such as the regulation of transcription and 
regulation of the cell cycle. Cluster One is also enriched for genes involved in the 
vascular endothelial growth factor (VEGF) pathway, which has been associated with lung 
injury and wound repair104,105. In contrast, Cluster Two (higher expression in smoky coal 
users) is dominantly enriched for inflammatory pathways such as hedgehog signaling, 
Toll-like receptor signaling, and cytokine-cytokine receptor interactions. In particular, we 
observed a propensity for the activation of pro-inflammatory mediators (e.g. IL-8, IL-1β, 
and WNT5B) in subjects who burned smoky coal. Genes LRIG1, G0S2, and IL-8 from 
Cluster Two also significantly overlapped with a signature that was generated in 
immortalized human lung epithelial cells following oncogenic KRAS overexpression106. 
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This is noteworthy given that lung tumors of nonsmokers exposed to smoky coal 
emissions have been demonstrated to harbor distinct KRAS mutations as compared to 
other nonsmoker lung tumors107.  
3.2.4 Shared Response to Tobacco Smoke Exposure 
We have previously shown that tobacco smoke induces gene-expression changes 
throughout the epithelium of the respiratory tract23. Since tobacco smoke is a complex 
mixture that is an established risk factor for lung cancer and other non-malignant 
respiratory diseases, we were interested to examine whether there are similarities between 
the effects of smoky coal and tobacco smoke exposure. We first re-examined smoking-
associated transcriptomic changes that were previously detailed in buccal mucosal 
biopsies from current and never smokers108. Our GSEA results indicate that Cluster One 
and Cluster Two from the 282-gene signature are concordantly changed in current versus 
never smokers (Figure 3.5). Thus, a significant number of the genes that were induced in 
smoky coal users are enriched among the genes induced in smokers from the buccal 
biopsy dataset. We found a similar relationship for the genes repressed in smoky coal 
users and genes repressed in smokers. Furthermore, our smoky coal signature appears to 
be modulated throughout the buccal, nasal and bronchial epithelium of current and never 
smokers (Figure 3.6).  
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3.3 Methods 
Subject Recruitment 
The subjects included in this analysis were enrolled as part of a larger HAP study 
that comprehensively characterized residential solid fuel usage and personal indoor 
exposure levels to HAP from residences in 30 rural villages throughout the counties of 
Xuanwei and Fuyuan in Yunnan Province, China102,109. Up to five households were 
selected from each village using the following criteria: i) the household contains the 
presence of a non-smoking, healthy female aged 20-80 who is primarily responsible for 
cooking; ii) the residence contains a stove using solid fuel; iii) the resident has used the 
same cooking and heating equipment for the past 5 years; iv) the residence is at least a 
decade old. The solid fuel type used at each residence was recorded based on self-report 
and further corroborated by petrochemical analysis of collected coal samples101. All 
participants provided informed consent. This study was approved by the NIH’s 
Institutional Review Board and was conducted in accordance to the World Medical 
Association Declaration of Helsinki’s recommendations for human subject protection.  
	  
Household Air Pollution Sampling 
Two sequential indoor personal 24-hr air measurements were collected from each 
subject and analyzed for concentrations of particulate matter with an aerodynamic cut-off 
of 2.5 µm (PM2.5), in addition to gas phase and particle bound polycyclic aromatic 
hydrocarbons (PAHs) as previously described102,109. Briefly, each subject was outfitted 
with a hip bag containing a personal sampling pump (AFC400S, BGI Inc., Waltham, 
MA) running at a median flow rate of 3.3L/min. This enabled the collection of particulate 
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matter on 37 mm Teflon filters via a cyclone that was placed in proximity to the subject’s 
breathing zone. 	  
 
 
 
 
 
 
Figure 3.1. Overview of sample collection for HAP Study 
PM2.5 concentrations (µg/m3) were calculated by dividing the post- minus pre-
weight of the filters by the volume of air drawn through the filters. For a subset, the 
organic fraction of the particulate matter was solvent extracted, whereupon the 
concentration of particle bound PAHs was determined using chromatography-mass 
spectrometry. Gas phase PAHs were measured using XAD2 absorbent tubes, which were 
attached in parallel to the personal sampling devices and analyzed similarly as the 
particulate matter102. 
Buccal Epithelial Cell Collection 
Buccal mucosa epithelial cell scrapings were collected on the morning 
commencing the 24-hr HAP sampling measurements. Sample collection was largely 
performed as previously described110. Briefly, a custom concave plastic tool with serrated 
edges (Plastronics Engineering, Hampstead, NH) was used to gently scrape against the 
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buccal mucosa on the inside left cheek 5 times and then placed immediately into 1 mL of 
RNAlater (Qiagen, Valencia, CA). The procedure was then repeated for the right cheek, 
whereupon the cellular material was combined into one tube. The cells were kept at room 
temperature for several days before being stored at -80°C until RNA isolation. Samples 
were initially stored in China and then transferred to the NCI on dry ice. Total RNA was 
isolated using miRNeasy Mini Kit (Qiagen, Valencia, CA). RNA integrity was assessed 
using an Agilent BioAnalyzer and RNA purity was confirmed using a NanoDrop 
spectrophotometer. Since buccal samples are prone to bacterial contamination and low 
yield due to partially degraded RNA22. Among the 201 buccal brushings that were 
isolated for RNA, 43 samples (21%) demonstrated sufficient quality and yield (total RNA 
≥100 ng) for microarray processing. We observed no significant differences between the 
distribution of smoky and smokeless samples that met the criteria for subsequent 
microarray preprocessing.   
 
Microarray Data Acquisition and Preprocessing 
Between 100 and 300 ng of total RNA was processed, labeled, and hybridized to 
Affymetrix Human Gene 1.0 ST GeneChips (Affymetrix Inc., Santa Clara, CA) 
according to the Affymetrix protocol as previously described79. By applying a custom 
CDF file67 which includes 19,741 entrez genes (“hugene10stv1hsentrezgcdf” and 
“hugene10stv1hsentrezg.db” packages), the robust multichip average algorithm in the 
‘affy’ package of Bioconductor was used for background adjustment, normalization, and 
probe-level summarization of the microarray samples. We then evaluated array quality 
and filtered outliers using principal components analysis (PCA), relative log expression 
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(RLE) and normalized unscaled standard error (NUSE) metrics. Therefore among the 43 
samples originally profiled, 35 samples representing unique individuals remained for 
smoky versus smokeless coal gene-expression analysis. All subsequent statistical 
analyses using this data were performed with R (http://r-project.org) 2-13.0 and 
Bioconductor111. In addition, the microarray data has been deposited in the Gene-
expression Omnibus under accession GSE64277. 
 
Smoky vs. Smokeless Coal Gene-Expression Analysis 
A Student’s t Test was used to identify buccal epithelial gene-expression changes 
significantly associated with exposure to the indoor burning of smoky versus smokeless 
coal (p < 0.005). Enrichr 1.0112 was then used to identify Kyoto Encyclopedia of Genes 
and Genomes (KEGG) pathways113, Gene Ontology (GO) biological processes114, and 
oncogenic signatures from the Molecular Signatures Database (MSigDB)115 that were 
significantly enriched (p < 0.05) among specific gene clusters. We also employed linear 
models to examine the variability in gene-expression that is attributable to PAHs and 
PM2.5, both before and after adjusting for smoky or smokeless coal use. In order to 
correlate these metrics with our smoky coal gene-expression signature, a composite 
metagene score was then generated to reflect first principal component of the z-score 
normalized signature for each of the 35 subjects.  
 
Connection to External Smoking Datasets 
Using raw gene-expression data downloaded from NCBI’s Gene-expression 
Omnibus116, we further examined the behavior of these genes in datasets that have been 
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derived from the intra- and extra-thoracic airway of current smokers and never smokers. 
Data from GSE17813108 containing mucosal biopsy samples from 39 current smokers and 
40 never smokers recruited from Weill Cornell Medical Center was RMA-normalized 
with the chip definition file (CDF) ‘hgu133plus2hsentrezgcdf’.  Applying a linear model 
adjusting for age, we ranked genes based on the t-statistic associated with active versus 
never smoking. Gene Set Enrichment Analysis (GSEA) v2.070 compared this ranked list 
to the genes significantly associated with smoky coal exposure. The behavior of our 
signature was also evaluated in nasal and bronchial brushing gene-expression data of 
current and never smokers from GSE898722 and GSE99419.  
 
Validation of Select Genes by Real-Time RT-PCR 
In order to confirm the differential expression results from our microarray 
analysis, we performed RT-PCR of select genes on an independent set of smoky (n=3) 
and smokeless (n=3) coal-exposed subjects. While the buccal samples from these subjects 
had minimal evidence of RNA degradation, they had been excluded from the original 
gene-expression profiling analysis due to low yield. RT-PCR was performed using SYBR 
Green-based RT² qPCR Primer Assays (Qiagen, Valencia, CA). Primers of the assays for 
candidate genes (IL-8, CASP3) and a control gene (GAPDH) were designed and 
experimentally verified by Qiagen to ensure uniform and high PCR efficiencies under 
standardized amplification condition. GAPDH was used as the housekeeping gene to 
normalize all samples. RNA samples were treated with gDNA Elimination Buffer to 
remove any contaminating genomic DNA and reverse transcribed with a mix of random 
hexamers and oligo-dT primer to generate first-strand cDNA, using Qiagen’s RT² First 
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Strand Kit. PCR amplification mixtures (25 µl) contained 9 ng of template cDNA, 12.5 µl 
of 2× RT² SYBR Green master mix (Qiagen) and 400 nM RT² qPCR primers. Forty 
cycles of amplification and data acquisition were carried out in StepOnePlus Real-Time 
PCR systems (Applied Biosystems). StepOne Software (version 2.2.2; Applied 
Biosystems) automatically performed threshold determinations for each reaction. All 
real-time PCR experiments were carried out in triplicate on each sample (mean of the 
triplicate shown).  Relative gene-expression levels were calculated using the comparative 
CT method117. Smoky versus smokeless fold changes were calculated from the average 
expression values obtained across each exposure group. 
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Table 3.1 Overview of 35 subjects profiled for HAP study.  
*Statistically significant (p<0.01) via Wilcoxon-Mann-Whitney Test or Fisher’s Exact Test.   
aPersonal filters for PAH analysis available for all but one subject 
 
 
 
 
 
 
 
	  
  
Smoky Coal 
(n=26) 
 
Smokeless Coal 
(n=9) 
Age mean ± SD 57 ± 15  59 ± 14 
Secondhand Smoke N (%) 26 (100.0) 9 (100.0) 
PM2.5 (ug/m3) median (IQR) 177.2 (121.3) 145.1 (171.5) 
PAHsa (ng/m3) median (IQR)   
 Acenaphthylene 620.0 (619.7) 491.6 (323.1) 
 Benz[a]anthracene* 85 (81.3) 9.4 (16.8) 
 Benzo[a]pyrene* 60.9 (59.4) 10.6 (12.3) 
 Benzo[b]fluoranthene 96.7 (95.0) 19.4 (28.9) 
 Benzo[g,h,i]perylene* 69.8 (66.0) 12.7 (16.4) 
 Benzo[k]fluoranthene* 20.9 (22.8) 5.2 (5.8) 
 Chrysene 69.7 (89.8) 12.1 (16.4) 
 Dibenz[a,h]anthracene* 16.9 (28.9) 1.8 (7.0) 
 Fluoranthene 29.8 (62.7) 5.3 (4.9) 
 Fluorene 290.6 (380.0) 250 (73.4) 
 Indeno[1,2,3-cd]pyrene* 37.4 (31.3) 11.7 (12.5) 
 Napthalene 4416.7 (3743.6) 4220 (1833.9) 
 Phenanthrene 464.2 (513.5) 351.5 (172.5) 
 Pyrene 35.4 (77.4) 6.6 (6.4) 	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Table 3.2 Number of genes significantly associated with PM2.5 or individual PAHs. 
Genes were identified using a univariate linear regression model run across all subjects (n=35; 
Model 1.0), smoky subjects (n=26; Model 1.1), and smokeless subjects (n=9; Model 1.2). The 
number of genes associated with PM2.5 and each PAH were also identified aftering adjusting for 
fueltype (Model 2); p<0.005. 
 
 
 
 
 
 
 
 
 
 
Model 1.0 
P< 
Model 1.1 Model 1.2 Model 2 
Exposure Metric (n=35) (n=26) (n=9) (n=35) 
PM2.5 48 46 17 77 
Acenaphthylene 35 78 63 28 
Benz[a]anthracene 177 180 7 130 
Benzo[a]pyrene 352 385 11 228 
Benzo[b]fluoranthene 281 180 30 184 
Benzo[g,h,i]perylene 632 601 14 436 
Benzo[k]fluoranthene 315 334 14 212 
Chrysene 227 168 25 165 
Dibenz[a,h]anthracene 513 531 26 344 
Fluoranthene 92 96 243 67 
Fluorene 36 50 2 30 
Indeno[1,2,3-cd]pyrene 878 1130 29 608 
Napthalene 35 56 7 35 
Phenanthrene 30 40 27 28 
Pyrene 113 119 408 79 
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Table 3.3 Functional enrichment within gene clusters whose behavior is associated with 
household air pollution of burning smoky versus smokeless coal. Within Enrichr, p-values 
were calculated using Fisher Exact Tests under the assumptions of a binomial distribution and 
independence for probability of any gene belonging to any set. 
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Figure 3.2. Gene-expression changes in the buccal epithelium are associated with exposure 
to household air pollution of burning smoky versus smokeless coal.  
Unsupervised hierarchical clustering of 282 genes generated from a Student’s t Test (p<0.005) 
comparing smoky (n=26) and smokeless (n=9) coal-exposed subjects. The left-most color bar 
corresponds to the two main clusters of genes (rows) that separate the samples (columns) based 
on their relative expression with respect to fuel type. Red and blue intensities correspond to 
higher and lower expression, respectively.  
 
 
 
 
	  	  
	  	   56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	   57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Correlation between household PAH metrics and smoky coal gene-expression 
changes. Using principal component analysis, the 282-gene signature was summarized into a 
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composite metagene score across each of the 35 samples, and correlated (Pearson) with log-
transformed levels of PM2.5 and PAH measurements. Results outlined in red indicate that the 
corresponding PAH is classified as a probable human carcinogen in the US EPA’s Integrated 
Risk Information System (IRIS) database. 
 
 
 
 
 
 
 
 
 
Figure 3.4. Real-time RT-PCR and microarray expression levels of select candidates from 
the 282-gene signature. The log2 fold change of IL8 and CASP3 in buccal epithelial epithelium 
of smoky versus smokeless subjects as computed from microarrays (black) and RT-PCR 
(striped). Microarray results were averaged across smoky (n=26) and smokeless (n=9) coal users. 
RT-PCR results were averaged across an independent set of smoky coal (n=3) and smokeless 
(n=3) coal users. 
 
 
	  
Figure 3.5. Concordance of smoky coal signature with active smoking. (A) Behavior of genes 
associated with smoky vs. smokeless coal exposure (Cluster One and Cluster Two) in relation to 
those induced or repressed by cigarette smoke exposure, as identified using buccal biopsies from 
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current and never smokers in a study by Boyle et al. 2010108 (GSEA FDR<0.05). The bottom 
color bar represents the t statistic ranking or strength of association between the gene-expression 
changes and active smoking (red: increased in smokers, blue: decreased in smokers). Each 
vertical line represents one of the genes associated with differential coal exposure. The height of 
this bar represents the running GSEA enrichment score. Green vertical lines represent the leading 
edge genes responsible for the core enrichment of each gene set. B) Behavior of 10 leading edge 
genes from Cluster Two (boxed green lines in Figure 3.5A), as displayed in a supervised 
heatmaps generated across the smokers and never smokers from Boyle et al. (left), and subjects 
with exposure to smoky or smokeless coal (right). 
 
Figure 3.6. The buccal signature of smoky coal exposure is modulated throughout the intra- 
and extra-thoracic airway epithelium of current versus never smokers. The behavior of the 
282-gene smoky coal signature derived from the 35 Xuanwei and Fuyuan females was evaluated 
in independent gene-expression datasets generated from buccal biopsies, nasal brushings, and 
bronchial airway brushings collected from current smokers (CS) and never smokers (NS) in 
previously published studies. For each dataset, the smoky coal signature was collapsed into a 
composite metagene score and projected into NS and CS. *p-val<0.05. 
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3.4 Discussion 
It has been almost three decades since Mumford et al. published their seminal 
study linking the high lung cancer mortality rates in rural Xuanwei County, China to the 
domestic burning of smoky coal95. While several studies have examined the relative 
etiologic importance of different solid fuel emissions and also identified distinct PAH-
DNA adduct levels, mutational spectra, and polymorphisms associated with smoky coal 
exposure100,107,118–123, little is known regarding the underlying physiologic responses that 
smoky coal induces in comparison to other fuel types. To this end, the results from our 
study lend valuable insight to the differential host response associated with smoky coal 
versus smokeless coal exposure by comprehensively examining the landscape of gene-
expression changes present in the buccal epithelium.  
Using whole-genome expression profiling of the buccal epithelium, we have 
identified a set of genes with altered expression between healthy, nonsmoking women 
who are exposed to smoky or smokeless coal emissions. The RT-PCR validation of two 
candidate genes (IL-8, CASP3) from this signature further confirms the differential 
molecular activity observed between the two exposure groups. Notably, we observe the 
significant activation of inflammatory mediators (IL-8, IL-1β, and WNT5B) and pathways 
(cytokine-cytokine interaction, Toll-like receptor signaling) in the buccal epithelium of 
subjects who burned smoky coal as compared to smokeless coal. Although exposure to 
particulate matter is known to activate these pathways in airway epithelial cells124,125, the 
comparable levels of PM2.5 detected in smoky and smokeless coal burning residences 
suggests that other constituents may be responsible for triggering this molecular response. 
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Specifically, we have validated the greater than two-fold activation of IL-8, a 
neutrophil chemoattractant involved in the TLR pathway that has previously served as a 
marker to evaluate the inflammatory effects of ambient particulate matter, ozone, and 
vehicle emissions on respiratory epithelial cells126–129. This differential human response 
parallels those examined by Dutta et al., who noted elevated IL-8 serum levels in rural 
Indian women who cooked with biomass compared to those who cooked with liquefied 
petroleum gas130. The activation of IL-8 has also been observed in the bronchial airway 
epithelium of smokers with lung cancer4,131. Overall, these molecular observations show 
that the exposure to smoky coal emissions mounts a strong inflammatory host response. 
Our transcriptomic examination of the buccal epithelium also suggests that the 
physiologic response to smoky coal exposure alters the expression of genes involved in 
apoptosis and cell proliferation. For instance, we observed that the pro-apoptotic gene 
CASP3 exhibits lower expression levels in smoky coal users. Activated downstream of 
initiator caspases as part of the intrinsic apoptosis pathway, caspase-3 plays a central role 
in orchestrating programmed cell death132. Decreased levels of CASP3 has been 
associated with apoptosis resistance, which is a hallmark of carcinogenesis and tumor 
progression133. Furthermore, tumor cells in non-small-cell lung cancer are highly 
apoptosis resistant and the in vivo expression level of CASP3 been shown to correlate 
with lung cancer survival134. Thus, our observation that smoky coal users have lower 
CASP3 levels biologically supports the high rates of lung cancer and lung cancer 
mortality rates observed in smoky coal users. We also observed an enrichment of genes 
that negatively regulate cell proliferation among smoky coal users.  
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We also compared our smoky coal signature to gene-expression changes found in 
the extra-thoracic epithelium of tobacco smokers. Through our GSEA analysis, we 
observed that our 282-gene signature was concordantly enriched in tobacco smoke-
associated gene-expression profiles derived from the buccal mucosa biopsies of current 
and never smokers, suggesting that components of smoky versus smokeless coal 
emissions may elicit similar physiologic effects as those induced by tobacco smoke. 
Among the 10 leading edge genes – the subset that was concordantly activated in both 
datasets and accounted for the core enrichment signal in our GSEA analysis – was 
polyamine oxidase PAOX, which has been recognized to play a role in catalyzing the first 
step of the xenobiotic response to inhaled toxicants135. Another leading edge gene was 
CLCA1, which has been demonstrated to regulate airway mucous production in 
inflammatory conditions such as asthma and COPD136,137. The activation of CLCA1 is 
also associated with mucin production in cigarette smoke-exposed human bronchial 
epithelial cell lines and murine models138. It has been previously observed that smoky 
coal exposure in Xuanwei reduces risk of lung cancer from tobacco use139,140. This 
phenomenon has also been observed in a cohort of workers exposed to high levels of 
diesel engine exhaust141. One possible mechanism suggested for these effects has been 
increased production of mucous airway levels by these environmental exposures, 
potentially providing some protection against tobacco’s carcinogenic effects141. Our 
observation that smoky coal exposure induces genomic changes consistent with high 
levels of mucous production provides some support for this hypothesis.  
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This is the first time gene-expression profiling of the buccal epithelium has been 
integrated within the framework of human field studies in Xuanwei, China. We have 
demonstrated that the exposure to smoky versus smokeless coal may induce an airway-
wide field of genomic changes that are present throughout the intra- and extra-thoracic 
airway epithelium. This phenomenon has been consistently observed in the response to 
tobacco smoke20,22 and thereby enabled the development of airway-based gene-
expression biomarkers for the early detection of lung cancer and for guiding therapy in 
COPD. We believe that by extending this genomic profiling approach to assess the 
biologic response to solid fuel emissions, this work will similarly open additional 
avenues for the future development of clinically relevant biomarkers in this population. 
There are a number of limitations to our study. The sample size was relatively 
small and the findings require future replication. However, we note that our report 
represents the first effort to characterize the transcriptome in people who experience this 
highly carcinogenic exposure and the overlap to some extent with the gene-signature 
associated with tobacco smoking provides some external validity to the findings. In 
addition, a substantial number of samples were not found to have analyzable mRNA. 
However, the characteristics of subjects with and without analyzable samples were not 
materially different and as such it is unlikely that this would have resulted in bias to our 
findings.  
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3.5 Conclusions  
In summary, this is the first study to employ whole-genome expression profiling 
of the buccal epithelium to measure the physiological response to HAP. Applying this 
“field of injury” paradigm to populations in China with high levels of HAP has enabled 
us to demonstrate differences in the physiologic response to smoky versus smokeless coal 
exposure. Specifically, our observation of increased IL-8 expression and decreased 
CASP3 expression in smoky coal users suggests that the physiologic response to smoky 
coal modulates pro-inflammatory and apoptotic responses. Our results also suggest a 
shared molecular response in the airway epithelium to tobacco smoke and smoky coal 
exposure.  
Together, these findings lend mechanistic insight and biologic plausibility to prior 
epidemiological studies that have strongly linked the variability in lung cancer risk within 
this region to the exposure of smoky coal. Additional in vitro and in vivo studies should 
be performed to characterize the molecular mechanisms that appear to be modulated with 
smoky coal exposure. Further genomic studies of the upper airway epithelium are also 
needed among women with smoky coal exposure who do or do not develop lung cancer 
in order to both fully characterize the molecular pathways associated with disease and 
develop a biomarker of disease risk for this sub-population. The concepts and results 
presented may be directly translatable to exposure and risk assessment to guide future 
HAP-related exposure studies conducted within this population and beyond.	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CHAPTER FOUR: 
Transcriptomic Effects of Electronic Cigarette Vapor 
Exposure in Bronchial Epithelial Cells Exposed In Vitro and In Vivo 
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4.1 Introduction 
Electronic cigarettes (ECIGs) are tobacco-free nicotine delivery systems that are 
marketed as safer alternatives to traditional tobacco cigarettes (TCIGs) as well as an aid 
for smoking cessation. Despite the limited research that is available to corroborate these 
health claims, there has been an increasing trend in the awareness, experimentation and 
ever use of ECIGs since they were first introduced to the U.S. market in 2007142. 
Specifically, the CDC reports that the ever use of ECIGs among U.S. adults increased 
from 3.3% to 8.5% during 2010-2013 and that over one-third of smokers had tried in an 
ECIG in 2013 alone143.   
While the FDA has proposed to extend its authority over ECIGs, they have yet to 
officially fall under the administration’s regulatory jurisdiction144. In the absence of 
federal regulation, ECIGs are subject to a lack of production standards. Of note, ECIG 
manufacturers are not required to fully disclose the list of ingredients used in the 
formulation of base liquids and flavorings. Furthermore, 10 states and the District of 
Columbia still permit ECIG sales to people of any age including minors145. In fact, it was 
reported that ECIG use among high school students tripled in just two years between 
2011-2013 to 4.5 percent146. As the prevalence of ECIG use continues to rise in youths 
and adults alike, there is an urgent unmet need to evaluate their association with 
unexpected health outcomes. 
ECIGs represent a major research challenge especially because they encompass a 
set of rapidly evolving devices. Unlike combustible cigarettes, ECIGs commonly have a 
battery-operated heating element and a reservoir that contains variable concentrations of 
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nicotine dissolved in a primary solvent of glycerol and/or propylene glycol. Flavorings 
are often added to the solution. Puffing on the device activates the heating element, which 
aerosolizes the nicotine solution into a mist of droplets or what is commonly referred to 
as “vapor”.  
Currently, three main generations or variants of ECIG devices have been defined: 
(1) disposable and rechargeable devices which mimic the aesthetics of TCIGs, (2) 
refillable tank-based devices and (3) customizable devices with power-controlled 
vaporizers. To date, there are more than 460 brands of electronic nicotine delivery 
systems, with over 7,700 flavors available to consumers147. Since the performance of 
aerosol delivery can vary greatly by brand and design148, it is important to utilize an 
equally dynamic system with which to evaluate these products.  
In order to facilitate the appropriate science-based regulation of ECIGs, it is 
critical to be able to leverage efficient and reliable means of characterizing the cellular 
and physiologic effects of these products. In this chapter, we thus examine the relevance 
of gene-expression profiling results generated from (1) an in vitro model system of 
exposure and (2) the bronchial airway epithelium of smokers and ECIG users in order to 
elucidate the biological ramifications of the exposure to these products (Figure 4.1). 	  
4.2 Results  
4.2.1 Chamber Exposures of ALI-Differentiated HBECs 	  
Six types of smoking chamber experiments were performed on ALI-differentiated 
HBECs, from which RNA was subsequently isolated and hybridized onto whole-genome 
expression arrays (Table 4.1). This included whole tobacco smoke from TCIGs, classic 
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tobacco and menthol-flavored aerosols from disposable ECIGs, as well as puffed air as a 
control. Each set of flavored-ECIG exposures was conducted twice: once with the 
addition of 13-16 mg of nicotine, and once without. All six groups of HBEC experiments 
were performed in triplicate, for a total of 18 samples. TCIGs and Air Control 
experiments were performed for 200 minutes at a rate of 2 puffs per minute, while ECIG 
exposures were performed for 400 minutes at a rate of 1 puff per minute.   
4.2.2 Detection of Exposure-Related Genes In Vitro 
 By applying PCA across all 19,718 genes, we observed that both groups of ECIG- 
and TCIG-exposed HBECS clustered separately from Air Controls (Figure 4.2). Upon 
performing an ANOVA analysis across all six groups, the majority of resulting gene-
expression changes were attributed to differences between the TCIG-exposed and Air 
Control samples (Figure 4.3). After excluding the TCIG samples and re-running the 
analysis, we were able to detect a finer resolution of changes associated with the four 
groups of ECIG exposures. Using this approach, we detected 244 differentially expressed 
genes (p<0.005) that resolved into four main clusters (Figure 4.4). These clusters were 
highly representative of a range of biological processes including but not limited to 
cilium organization, the response to oxidative stress, and apoptosis. Select genes from 
each representative cluster illustrate how certain transcriptomic changes were shared 
between TCIG and ECIG exposures, while others were more pronounced in response to 
one type of exposure over the other (Figure 4.5). 
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4.2.3 Influence of Flavor and Nicotine 
 We detected significantly more gene-expression changes that were associated 
with ECIG flavorings as compared to the addition of nicotine (Figure 4.6). Specifically, 
127 genes (p<0.001) were differentially expressed among HBECs exposed to the classic 
tobacco-flavored ECIGs (n=6) versus menthol-flavored ECIGs (n=6). Compared to the 
menthol-flavored ECIGs, the tobacco-flavored exposures appeared to be associated with 
the activation of cell cycle-related genes such as TP63, PRKDC, and DLG1. This was in 
contrast to the 39 genes (p<0.001) with altered expression levels between HBECs 
exposed to flavored-ECIGs with (n=6) and without (n=6) the 13-16 mg addition of 
nicotine. This signature included the activation of nicotine-metabolizing and aryl-
hydrocarbon receptor-related genes including CYP1A1, CYP1B1, NQO1 and EGFR.  
Interestingly, we also observed that all pairwise group comparisons relative to Air 
Controls exhibited significantly concordant behavior with a previously generated set of 
bronchial airway gene-expression changes that have been elucidated in smokers20 (Figure 
4.7). These physiologically relevant gene-expression responses were significantly 
induced with traditional cigarette chamber exposures and also enriched across all groups 
of our in vitro ECIG exposures, irrespective of the flavoring used or presence of nicotine.  
4.2.4 Study Population for In Vivo ECIG Study 
Thus far, we have profiled the bronchial gene-expression patterns of 10 former 
smokers and 8 former smokers who are current ECIG users (Table 4.2). All subjects were 
required to have abstained from TCIGs for at least three months at the time of 
bronchoscopy. Subjects were well matched in terms of gender, age, RIN and pack-years. 
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We did notice, however, that the ECIG users reported a more recent and narrow range of 
TCIG quit dates (5-12 months prior to time of bronchoscopy) as compared to the former 
smokers (4-354 months prior to time of bronchoscopy). The ECIG users primarily 
employed second or third generation vaporizing devices and switched between an 
average of four flavored e-liquids with a nicotine strength that ranged between 6-24 
mg/mL (data not shown).   
4.2.5 ECIG-Associated Gene-Expression Changes in the Bronchial Airway 
 We identified 199 differentially expressed genes between the former smokers and 
current ECIG users (p<0.005; 2x more than expected by chance). The hierarchical 
clustering of these genes across the two exposure groups is illustrated in Figure 4.7. One 
of the eight ECIG users elicited an expression profile similar to that of a former smoker. 
Together, these ECIG-associated alterations were significantly enriched for a number of 
biological and molecular processes including the induction of nicotinic and Wnt-activated 
receptor activities (Table 4.4). While we did not observe significant enrichment with the 
gene sets derived from our in vitro HBEC exposures, we did observe the concordant 
activation of bronchial airway genes that have been documented to be elevated in current 
smokers and rapidly reversible upon smoking cessation in former smokers (Figure 4.8).  
4.3 Methods 
ALI-Cultured HBECs and Chamber Exposures 
Well-differentiated epithelial cell cultures were established using previously 
published protocols149,150. Briefly, the ALI system was comprised of a normal cell culture 
well with a membranous insert positioned halfway into the well. After HBECs were 
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seeded onto the insert, the bottom of the well was filled with cell culture media such that 
cells were simultaneously exposed to air and to liquid media in order to mimic the 
physiologic conditions of the lung. Culture initiation was followed by 7-10 days for 
proliferation and 21 days for differentiation. On the 21st day of ALI differentiation, 
HBEC cultures were exposed to one of the following conditions in a smoking chamber: 
(1) Air controls with 48 puffs (1 puff/min), (2) Whole tobacco smoke from traditional 
cigarettes (TCIGs) at 48 puffs (1 puff/min), (3) Tobacco-flavored ECIGs (ECIG_T) at 
400 puffs (2 puffs/min), (4) ECIG_T with nicotine [13-16 mg] at 400 puffs (2 puffs/min), 
(5) Menthol-flavored ECIGs (ECIG_M) at 400 puffs (2 puffs/min), and (6) ECIG_M 
with nicotine [13-16 mg] at 400 puffs (2 puffs/min). All ECIG exposures were conducted 
using disposable blu eCigs® products. Puff topographies were selected to mimic 
physiologic conditions of exposure, and to mitigate toxic cellular responses. After being 
exposed, the cells sat overnight in an incubator before being frozen down for RNA 
isolation. Exposures were performed in triplicate. 
 
Subject Recruitment for In Vivo Bronchial Gene-Expression Study 
The subjects profiled in this study include former smokers and former smokers who 
currently use ECIGs.  At BUMC and UCLA, the following criteria were used to qualify 
subjects as Former Smokers or ECIG Users:  
Former Smokers 
• Smoked >= 5 cpd 
• Smoked >= 2 years 
• Quit smoking for >= 3 months 
• Used E-Cigs < = 2 times and not within last 2 weeks 
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E-Cig Users 
• Smoked >= 5 cpd 
• Smoked >= 2 years 
• Quit smoking for >= 3 months 
• Using E-Cig for >= 1 month 
• Uses E-Cig >= 6 days per week 
 
The Institutional Review Boards of both medical centers approved the protocols involved 
in this study, and all subjects provided written informed consent. 
 
Bronchial Airway Epithelial Cell Collection 
The collection, storage and RNA isolation of bronchoscopy brushings were 
performed as previously described4. Briefly, bronchial airway epithelial cells were 
obtained from the uninvolved right mainstem bronchus with an endoscopic cytobrush. 
Brushes were then placed in TRIzol (Invitrogen) and stored at -80°C prior to RNA 
extraction.  
 
Microarray Data Acquisition and Preprocessing 
RNA collected from both in vivo and in vitro ECIG exposure studies were 
separately isolated, hybridized, and profiled onto Gene ST 1.0 arrays as described in 
previous chapters. The gene-expression data was subsequently normalized using RMA 
and CDF v17.0 in R-2.15.0. Array quality was evaluated using NUSE, RMA and PCA 
metrics. 
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Figure 4.1. Overview of ECIG exposure studies. 
 
Differential Expression Analysis of in vitro Exposure Data 
 
Individual two-sample Student’s t Tests were used to identify gene-expression 
changes between each of the five main types of exposure (TCIG, ECIG menthol, ECIG 
menthol with nicotine, ECIG tobacco, ECIG tobacco with nicotine) compared to Air 
Control conditions. These results were used to generate gene sets (p<0.005) that were 
subsequently examined with respect to external smoking datasets using GSEA. An 
ANOVA approach was also employed to detect major gene-expression changes across all 
exposure groups including Air Controls. However, since TCIGs were observed to drive a 
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large number of transcriptomic changes, an alternate ANOVA analysis was implemented 
in comparison wherein the TCIG exposure group was excluded.  
Finally, linear regression methods were used to examine the potential interaction 
between nicotine and flavorings additives in ECIGs. For each probeset i in patient j, the 
relationship between log2 expression levels (ge), nicotine (Xnicotine =1 for exposures with 
nicotine and 0 without nicotine), flavor (Xflavoring=1 for tobacco and 0 for menthol), and 
the interaction between nicotine and flavoring was assessed using the following models: 
 
 Geneij = β0 + βflavor*Xflavor + βnicotine*Xnicotine + εi     (1) 
 
  Geneij = β0 + βflavor*Xflavor + βnicotine*Xnicotine + βflavor:nicotine* Xflavor *Xnicotine + εi (2) 
 
 
In these models, the term β0 represents the intercept and the term εi represents the 
error, which we assumed to be normally distributed. The probeset was considered 
associated with the flavor:nicotine interaction term if an ANOVA comparing model (2) to 
model (1) generated a significant p-value. Genes that were significant for the interaction 
term were removed from the expression matrix prior to examining changes independently 
associated with flavor and nicotine. 
 
Analysis of Bronchial Gene-Expression Data 
ECIG-associated changes in bronchial airway gene-expression were identified 
using a Student’s t Test. The False Discover Rate (FDR) for each gene was computed 
using Benjamini and Hochberg corrections68. Enrichment analyses in relation to 
independently generated gene sets and curated annotations were performed using GSEA 
and Enrichr as described in previous chapters. Specifically in this study, the 
	  	   75 
transcriptomic landscape of ECIG-associated changes was used as a rank list and 
compared to gene sets compiled from Beane et al. 2007. This included groups of genes 
that were first identified as differentially expressed in the bronchial airways of current 
versus never smokers and then further characterized as irreversible or rapidly reversible 
based on their behavior in former smokers20.   
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Table 4.1 Overview of in vitro ALI-differentiated HBEC exposures profiled on microarrays.  	  	  	  	  	  	  	  
	  
Table 4.2 Demographic overview of subjects profiled for in vivo ECIG study.  
Geometric mean (SD); Median [range]; p-values were calculated using Student’s t Test or 
Fisher’s Exact Test. *information available for 7 subjects 	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Table 4.3 Functional enrichment of gene clusters corresponding to gene-expression analysis 
of in vitro exposures. Clusters (C1-C4) represent groups of differentially expressed genes are 
illustrated in Figure 4.4. This table displays top corresponding gene ontologies for which these 
genes are significantly enriched (p<0.05).  
 
  
Gene$Cluster$1$(C2)
Enriched$Gene$Ontology$(GO)$Term Adjusted$P=value Z=score
microtubule+based/process/(GO:0007017) 1.01E+10 +2.43
cell/projection/assembly/(GO:0030031) 1.11E+08 +2.30
microtubule+based/movement/(GO:0007018) 2.64E+08 +2.30
cilium/assembly/(GO:0042384) 6.39E+08 +2.25
cilium/organization/(GO:0044782) 8.65E+08 +2.26
cellular/component/assembly/involved/in/morphogenesis/(GO:0010927) 1.92E+07 +2.33
cilium/movement/(GO:0003341) 1.72E+06 +2.54
organelle/assembly/(GO:0070925) 7.65E+06 +2.42
ventricular/system/development/(GO:0021591) 1.25E+04 +2.66
intraciliary/transport/(GO:0042073) 5.75E+04 +2.60
cytoskeleton+dependent/intracellular/transport/(GO:0030705) 7.74E+04 +2.23
Gene$Cluster$2$(C2)
Enriched$Gene$Ontology$(GO)$Term Adjusted$P=value Z=score
response/to/corticosterone/(GO:0051412) 4.17E+02 +2.54
response/to/mineralocorticoid/(GO:0051385) 4.17E+02 +2.51
response/to/steroid/hormone/(GO:0048545) 4.17E+02 +2.45
response/to/oxidative/stress/(GO:0006979) 4.17E+02 +2.37
regulation/of/cysteine+type/endopeptidase/activity/involved/in/apoptotic/process/(GO:0043281) 4.17E+02 +2.36
response/to/extracellular/stimulus/(GO:0009991) 4.62E+02 +2.43
regulation/of/cysteine+type/endopeptidase/activity/(GO:2000116) 4.17E+02 +2.35
response/to/cAMP/(GO:0051591) 4.17E+02 +2.33
response/to/purine+containing/compound/(GO:0014074) 4.17E+02 +2.32
response/to/organophosphorus/(GO:0046683) 4.17E+02 +2.30
response/to/progesterone/(GO:0032570) 4.89E+02 +2.32
response/to/topologically/incorrect/protein/(GO:0035966) 4.62E+02 +2.23
Gene$Cluster$3$(C3)
Enriched$Gene$Ontology$(GO)$Term Adjusted$P=value Z=score
cellular/ketone/metabolic/process/(GO:0042180) 1.31E+04 +2.24
dicarboxylic/acid/biosynthetic/process/(GO:0043650) 7.69E+03 +3.06
kynurenine/metabolic/process/(GO:0070189) 7.69E+03 +2.68
cellular/modified/amino/acid/catabolic/process/(GO:0042219) 1.26E+02 +2.91
benzene+containing/compound/metabolic/process/(GO:0042537) 1.76E+02 +2.61
quinone/metabolic/process/(GO:1901661) 2.27E+02 +2.62
Gene$Cluster$4$(C4)
Enriched$Gene$Ontology$(GO)$Term Adjusted$P=value Z=score
NADP/metabolic/process/(GO:0006739) 8.48E+04 +2.84
glucose/catabolic/process/(GO:0006007) 1.56E+03 +2.90
NADPH/regeneration/(GO:0006740) 1.56E+03 +2.89
pentose+phosphate/shunt/(GO:0006098) 1.56E+03 +2.87
pentose/metabolic/process/(GO:0019321) 1.56E+03 +2.66
pyridine/nucleotide/metabolic/process/(GO:0019362) 1.56E+03 +2.35
nicotinamide/nucleotide/metabolic/process/(GO:0046496) 1.56E+03 +2.35
pyridine+containing/compound/metabolic/process/(GO:0072524) 2.14E+03 +2.34
oxidoreduction/coenzyme/metabolic/process/(GO:0006733) 2.41E+03 +2.25
hexose/catabolic/process/(GO:0019320) 9.17E+03 +2.54
monosaccharide/catabolic/process/(GO:0046365) 1.21E+02 +2.39
removal/of/superoxide/radicals/(GO:0019430) 2.42E+02 +2.53
cellular/response/to/oxygen/radical/(GO:0071450) 2.42E+02 +2.53
cellular/response/to/oxidative/stress/(GO:0034599) 2.47E+02 +2.26
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Table 4.4 Functional enrichment of genes associated with ECIG exposure in vivo. The top  
biological and molecular processes for which the 199 genes differentially expressed between 
ECIG users and former smokers (Figure 4.7) are enriched.  	  
	  	  
Up#regulated,in,ECIG,Users,(n=130,genes)
Enriched,Gene,Ontology,(GO),Biological,Process P#value Z#score
adult&feeding&behavior&(GO:0008343) 2.31E>03 >2.77
regulation&of&beta>amyloid&formation&(GO:1902003) 2.71E>03 >2.78
regulation&of&Wnt&signaling&pathway,&planar&cell&polarity&pathway&(GO:2000095) 2.71E>03 >2.51
vasculature&development&(GO:0001944) 2.88E>03 >2.31
negative&regulation&of&JUN&kinase&activity&(GO:0043508) 3.62E>03 >2.76
regulation&of&amyloid&precursor&protein&catabolic&process&(GO:1902991) 3.62E>03 >2.76
planar&cell&polarity&pathway&involved&in&neural&tube&closure&(GO:0090179) 3.62E>03 >2.68
regulation&of&establishment&of&planar&polarity&involved&in&neural&tube&closure&(GO:0090178) 4.13E>03 >2.70
regulation&of&non>canonical&Wnt&signaling&pathway&(GO:2000050) 4.13E>03 >2.60
muscle&organ&development&(GO:0007517) 4.47E>03 >2.13
convergent&extension&(GO:0060026) 4.66E>03 >2.67
regulation&of&microtubule>based&movement&(GO:0060632) 4.66E>03 >2.52
muscle&structure&development&(GO:0061061) 4.91E>03 >2.12
Enriched,Gene,Ontology,(GO),Molecular,Process P#value Z#score
Osteoblast&Signaling 2.88E>03 >1.87
Nicotine&Activity&on&Dopaminergic&Neurons 5.93E>03 >1.86
adenylate&cyclase>activating&G>protein&coupled&receptor&signaling&pathway&(GO:0007189) 3.55E>02 >2.03
regulation&of&cyclic&nucleotide&biosynthetic&process&(GO:0030802) 3.56E>02 >2.04
positive&regulation&of&response&to&external&stimulus&(GO:0032103) 3.59E>02 >2.19
regulation&of&nucleotide&biosynthetic&process&(GO:0030808) 3.79E>02 >2.05
regulation&of&purine&nucleotide&biosynthetic&process&(GO:1900371) 3.79E>02 >2.04
regulation&of&cell&projection&assembly&(GO:0060491) 3.87E>02 >2.08
regulation&of&vesicle>mediated&transport&(GO:0060627) 4.06E>02 >2.19
Downregulated,in,ECIG,Users,(n=69,genes)
Enriched,Gene,Ontology,(GO),Biological,Process P#value Z#score
DNA&replication&checkpoint&(GO:0000076) 7.38E>04 >2.61
ncRNA&metabolic&process&(GO:0034660) 3.97E>03 >2.33
mRNA&processing&(GO:0006397) 8.29E>03 >2.38
Enriched,Gene,Ontology,(GO),Molecular,Process P#value Z#score
NF>kappaB&binding&(GO:0051059) 3.67E>03 >2.98
oxidoreductase&activity,&acting&on&the&CH>NH&group&of&donors&(GO:0016645) 4.52E>03 >2.76
4&iron,&4&sulfur&cluster&binding&(GO:0051539) 8.32E>03 >2.58
methyltransferase&activity&(GO:0008168) 3.45E>02 >2.35
small&conjugating&protein&ligase&binding&(GO:0044389) 2.40E>02 >2.33
transferase&activity,&transferring&one>carbon&groups&(GO:0016741) 3.78E>02 >2.33
ubiquitin&protein&ligase&binding&(GO:0031625) 2.40E>02 >2.32
iron>sulfur&cluster&binding&(GO:0051536) 2.12E>02 >2.30
metal&cluster&binding&(GO:0051540) 2.12E>02 >2.28
DNA&helicase&activity&(GO:0003678) 1.36E>02 >2.26
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Figure 4.2. Principal Component Analysis across top 2k genes across six in vitro exposures. 
Top 2k variable genes were determined using Median Absolute Deviation (MAD). Each point 
(n=18) represents a culture of ALI-differentiated HBECs subsequently chamber exposed to one 
of the following six conditions: (1) Air Control (blue; n=3), (2) Whole tobacco smoke from 
TCIGs (red; n=3), (3) ECIG with tobacco flavoring (light purple; n=3), (4) ECIG with tobacco 
flavoring and nicotine (dark purple; n=3), (5) ECIG with menthol flavoring (light green; n=3), or 
(6) ECIG with menthol flavoring & nicotine (dark green; n=3). The x and y axes reflect the first 
and second principal components, respectively.  
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Figure 4.3. Genes derived from ANOVA across TCIG, ECIG and Air Control exposures in 
vitro. 117 genes were differentially expressed when gene expression across the six groups of 
exposure (q<0.0001), with the majority of changes occurring between and TCIG and Air Control 
conditions. From left to right: (1) Air Control (blue; n=3), (2) ECIG with menthol flavoring (light 
green; n=3), (3) ECIG with menthol flavoring and nicotine (dark green; n=3), (4) ECIG with 
tobacco flavoring (light purple; n=3), (5) ECIG with tobacco flavoring and nicotine (dark purple; 
n=3), (6) Whole tobacco smoke from traditional cigarettes (red; n=3).  	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Figure 4.4. Genes derived from ANOVA across ECIG and Air Control exposures in vitro.  
244 genes were differentially expressed when the TCIG group was excluded for the analysis 
(q<0.01). The heatmap above, however, includes all groups. The clustered samples from left to 
right: (1) Air Control (blue; n=3), (2) Whole tobacco smoke from traditional cigarettes (red; n=3), 
(3) ECIG with menthol flavoring (light green; n=3), (4) ECIG with tobacco flavoring and nicotine 
(dark purple; n=3), (5) ECIG with tobacco flavoring (light purple; n=3), (6) ECIG with menthol 
flavoring and nicotine (dark green; n=3). Four clusters gene clusters are denoted on the green bar 
to the left, with corresponding functional annotation in Table 4.3.  	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Figure 4.5. Boxplots of select genes from in vitro exposures. The log2 expression of a select 
gene from each of the four gene clusters as delineated in Figure 4.4. For each plot, the exposure 
groups from left to right are: (1) Air Control (blue; n=3), (2) ECIG with menthol flavoring (light 
green; n=3), (3) ECIG with menthol flavoring and nicotine (dark green; n=3), (4) ECIG with 
tobacco flavoring (light purple; n=3), (5) ECIG with tobacco flavoring and nicotine (dark purple; 
n=3), (6) Whole tobacco smoke from traditional cigarettes (red; n=3). 
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Figure 4.6. Nicotine and ECIG flavoring effects on gene-expression in vitro. (A) Hierarchical 
clustering of 127 genes (p<0.001) differentially expressed between classic tobacco (n=6) and 
menthol-flavored (n=6) ECIGs. (B) Boxplot of TP63, a select gene from the flavor-associated 
signature, plotted across six in vitro conditions (C) Hierarchical clustering of 39 genes (p<0.001) 
differentially expressed between ECIGs with (n=6) and without nicotine (n=6) [13-16mg]. (D) 
Boxplot of CYP1A1, a select gene from the nicotine-associated signature, plotted across six in 
vitro conditions For each boxplot, the experimental condition is as follows: (1) Air Control (blue; 
n=3), (2) ECIG with menthol flavoring (light green; n=3), (3) ECIG with menthol flavoring and 
nicotine (dark green; n=3), (4) ECIG with tobacco flavoring (light purple; n=3), (5) ECIG with 
tobacco flavoring and nicotine (dark purple; n=3), (6) Whole tobacco smoke from traditional 
cigarettes (red; n=3). 
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Figure 4.6. Genes activated with ECIG and TCIG exposures in vitro are enriched for airway 
changes associated with active smoking in vivo.  
Six gene sets (GS) were generated from two-group comparisons using Student’s t Tests 
(p<0.005). Gene Sets 1-5 represent genes that were significantly up-regulated in a specific type of 
ECIG or TCIG exposure (n=3) versus Air Control (n=3). Gene Set 6 consists of genes that were 
up-regulated when comparing nicotine-containing ECIG exposures (n=6) against Air Control 
(n=3). Using GSEA, GS1-6 were subsequently compared against a ranked list of t statistics 
generated from bronchial airway gene-expression changes of detected in current versus never 
smokers20 (GSEA q<0.05). 
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Figure 4.7. Unsupervised hierarchical clustering of bronchial airway genes associated with 
ECIG-exposure. Genes altered in ECIG users who were former smokers (Black; n=8) compared 
to former smokers (Grey; n=10) were detected using a Student’s t Test (n = 199 genes; p<0.005).  
  
Figure 4.8. Enrichment of rapidly reversible smoking genes in the airway of ECIG users. 
(A) GSEA plot where each vertical line represents one out of 46 genes identified in Beane et al. 
2007 as the most rapidly reversible tertile of genes to revert to baseline expression upon response 
to smoking cessation. The ranked list of changes is based on the t statistics generated from a 
Student’s t Test between ECIG users versus former smokers. 14 genes (genes) highlighted in red 
represent the core group of enriched genes amongst ECIG users (GSEA q<0.25). (B) Heatmap of 
the 14 core enriched genes, clustered between ECIG users (black; n=8) and former smokers 
(grey; n=10).  
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4.4 Discussion 
In the absence of federal regulations, it is imperative for the scientific community 
to leverage relevant biological models and clinical cohorts in order to comprehensively 
examine the physiologic effects of ECIGs. Here we took a two-pronged approach and 
investigated the genome-wide expression profiles of bronchial epithelial cells exposed to 
ECIG aerosols either in vitro or in vivo. The science-based evidence generated from these 
analyses and related future studies will be key for guiding the informed adoption of 
appropriate regulatory policies that can ensure the health of consumers.  
We first investigated the relative effects of ALI-differentiated HBECs that were 
subject to chamber exposures using TCIGs, a disposable first-generation ECIGs, and Air 
Controls. Despite the current lack of standardized puffing regimens for the laboratory 
examination of ECIG aerosols, the puffing topography of ECIG users has been 
demonstrated to significantly differ from traditional smoking behavior151. With this in 
mind, we applied the number maximal draws that could be taken from a single TCIG (48 
puffs) or first-generation ECIG cartridge (400 puffs)152,153.  
Upon incorporating all exposure groups into our initial analysis (Air Controls, 
TCIGs, two ECIG flavors with and without the addition of nicotine), we observed that 
whole tobacco smoke from TCIGs drove the majority of detectable gene-expression 
changes. This suggests that within the experimental parameters of our in vitro studies, 
ECIGs render relatively fewer gene-expression effects on airway epithelial cells as 
compared to those induced by TCIG exposure. These results resonate with the findings of 
Tayyarah and Long in 2014, whose analyte comparisons of machine-generated aerosols 
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indicated that TCIG smoke delivered significantly more harmful and potentially harmful 
constituents (HPHCs) per puff as compared to ECIG aerosol or to room air154.  
Nevertheless, we also observed that ECIG and TCIG exposures induce a number 
of shared gene-expression changes that are indicative of functional cellular responses. For 
instance, both whole tobacco smoke and ECIG aerosols down-regulated the expression of 
genes that are functionally enriched for cilium organization and movement. In all 
exposures relative to the air controls, we observed the decreased expression of 
intracellular transport genes (IFT81; IFT140; IFT17) and DYNC2H1, a component of 
cytoplasmic dynein involved in the retrograde transport motor. The effect of smoking on 
cilia abnormalities such as loss of length has previously been noted in the large and small 
airways epithelium of healthy smokers and smokers with COPD155. Our observation that 
ECIG exposures induce a similar set of effects on ALI-cultured HBECs suggests that 
these products should be further examined in terms of their impact on airway cilia 
signaling and mucociliary clearance.  
Furthermore, both ECIG and TCIG exposures appeared to activate genes that are 
involved in components of the protective response to oxidative stress and xenobiotic 
metabolism. As shown in our results, SLC7A11 was significantly activated in ECIG and 
TCIG exposure groups. This gene encodes for a cysteine/glutamate amino-acid transport 
system that is important for glutathione production and antioxidant defense 
mechanisms156. Interestingly, preliminary evidence suggests that the production of 
oxidant and reactive oxygen species may arise from ECIG heating elements in addition to 
the aerosol itself157.  We also observed the up-regulation of CYP3A5, which encodes for a 
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major cytochrome P450 enzyme that is an active element in the metabolism of steroid 
hormones and inhaled xenobiotics158,159. 
Moreover, we identified a set of genes that are particularly induced in response to 
ECIG exposure. Notably, this includes the aldo-keto reductase (AKR) gene AKR1C2, 
which was significantly activated in response to tobacco-flavored ECIGs regardless of 
whether nicotine was added. This corresponds to a family of isoenzymes that is thought 
to be important in defense mechanisms against reactive oxygen species and the metabolic 
activation of PAHs160. The kynurenine and glutamate oxaloacetate transaminase genes 
KYNU and GOT2 were similarly induced across the majority of ECIG exposures. Both of 
these genes are related to tryptophan catabolism, a pathway that has been implicated in 
chronic inflammatory lung diseases including idiopathic pulmonary fibrosis and 
sarcoidosis161. More recently, kynurenine has been identified as an endogenous ligand 
that activates the aryl-hydrocarbon receptor (AHR), thereby eliciting immunosuppressive 
effects in vitro in addition to promoting inflammation and cancer progression in 
vivo162,163. It will be important to conduct experiments that follow-up on the activation of 
these pathways in order to validate whether they are uniquely associated with ECIG 
exposure. 
While the sample size of our human airway studies is currently limited, we were 
able to detect a 199-gene signature of bronchial airway changes that are altered between 
former smokers and former smokers who use ECIGs. In particular, we noted that ECIG 
users exhibited higher airway expression levels of neuronal nicotinic acetylcholine 
receptor CHRNA3, the genetic variation of which has been shown to increase the 
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susceptibility to tobacco dependence and smoking-associated diseases such as lung 
cancer164. At the pathway level, we observed the induction of Wnt signaling receptor 
activity, which is a hallmark of lung tissue damage and inflammation165. Unsurprisingly, 
it is associated with cigarette smoke exposure and lung tumorogenesis166. To our 
knowledge, this is the first time Wnt signaling has been implicated in the physiologic 
response to ECIG exposure.  
Additionally, both of our human airway and chamber exposure ECIG studies 
demonstrate a strong enrichment of genes that have been previously identified as 
activated in the large airways of active smokers and down-regulated in the airways of 
former smokers20. While these results warrant further investigation, they indicate that 
genes capable of reverting to baseline upon smoking cessation instead remain elevated in 
expression with ECIG use.  
There are several limitations to our in vitro and human studies that should be 
taken into consideration for the design of future studies.  Notably, the bronchial airway 
brushings we have profiled thus far were obtained from former smokers. While we have 
preliminary evidence to suggest concordance between ECIG exposures and active 
cigarette smoke, it would be further illuminating to capture longitudinal profiles of active 
smokers before and after their transition to ECIGs. This would ensure that we tease out 
ECIG-specific responses as opposed residual TCIG effects. In addition, our in vitro 
studies were limited to the examination of a single brand of disposable, first-generation 
ECIGs. This greatly contrasts the wider range of ECIG exposures in our human studies, 
where subjects primarily used second and third generation ECI devices and switched 
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between an average of four flavors. As these cohorts expand, however, we can use them 
to inform us about the evolving preferences and behaviors of ECIG users such that the 
relevant parameters of future in vitro experiments can be modified accordingly. The 
continued implementation of these high-throughput approaches in additional clinical and 
experimental contexts will be highly impactful in addressing the myriad questions that 
remain about ECIG efficacy and safety. 
 
4.5 Conclusions  
This chapter features two ways in which we have used transcriptomic profiling of 
human bronchial epithelial cells to elucidate key insights concerning the cellular and 
physiologic implications of ECIG exposure. Results from our chamber exposures of 
differentiated airway epithelium indicate that while more gene-expression changes are 
incurred from the insult to whole tobacco smoke, there are number of shared biologically 
relevant processes that are modulated in response to both ECIG and TCIG exposures. 
This model also provides a valuable controlled environment in which gene-expression 
changes associated with ECIG flavorings, nicotine levels, and the combination thereof 
can be examined. Results from our human cohort studies suggest that a signature 
associated with ECIG-use can be detected in the airway epithelium. These gene-
expression changes are enriched for genes that are induced with TCIG exposure and 
revert to baseline upon smoking cessation, further bolstering the hypothesis that that 
components of the airway epithelium’s host response to ECIG and TCIG exposures are 
concordant. As an extension to the preliminary in vivo findings presented in this chapter, 
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we intend to examine the longitudinal impact of switching from active TCIG exposure to 
ECIG usage by comparing the transcriptomic landscape of the airway epithelium before 
and after transitioning to ECIGs. This will provide relevant insight into the potential 
implications of using ECIGs as a cessation product or to stave off the urge to smoke. 
Together, these approaches may be directly informative to tobacco control policies for 
regulating the future design, formulation, and intended use of ECIGs as well as other 
tobacco-related products.  
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CHAPTER FIVE: 
General Conclusions and Future Directions 	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The studies featured in this dissertation collectively use high-throughput 
transcriptomic profiling of the intra- and extra-thoracic airway epithelium to assess the 
physiologic impact of prolific sources of inhaled toxins. Importantly, the results from 
these chapters contend that: 	  
• Like the effects of mainstream tobacco smoke, the inhalation of environmental 
tobacco smoke induces a field of injury phenomenon wherein gene-expression 
profiles derived from the extra-thoracic nasal epithelium serve as biologically 
relevant indicators of exposure in children and adults. This approach 
complements traditional inhaled exposure assessment methods including personal 
and stationary environmental sampling by overcoming limitations with regard to 
capturing the biological nuances of exposure-response relationships.  
• Buccal epithelial gene-expression is able to elucidate biologically meaningful 
differences in the host response of subjects exposed to smoky versus smokeless 
coal. Similar to tobacco smoke, smoky coal emissions appear to render a high 
degree of pro-inflammatory effects throughout the airway epithelium. These 
associated genomic changes corroborate previous findings that implicate coal type 
as an important determinant in shaping the relationship between household air 
pollution and disease risk.   
• Transcriptomic profiles derived from bronchial epithelial cells exposed either in 
vitro or in vivo are amenable for characterizing the relevant cellular and 
physiologic effects of electronic cigarettes. Results from both approaches indicate 
that a subset of these gene-expression changes is similarly incurred from exposure 
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to electronic cigarette aerosol and whole tobacco smoke in spite of their reported 
compositional differences.  
The integration of transcriptomics with other exposure assessment approaches may 
facilitate a holistic yet precise construction of the human airway epithelium’s exposome. 
In particular, it may help us detail the airway’s response to a compendium of inhaled 
exposures including those that are either well-established or potential risk factors for 
chronic lung disease. Additional work using longitudinal or supplementary prospective 
cohorts will determine whether the biological findings from these analyses yield 
meaningful implications for the prediction of related disease processes.  
To our knowledge, this body of work marks the novel application of human 
airway transcriptomics in assessing the exposure-response to three separate but equally 
complex inhaled environmental pollutants. These results make a case for how gene-
expression profiling can facilitate advancements in epidemiological studies, exposome 
research, and related efforts to elucidate underlying molecular mechanisms that may 
precipitate poor health outcomes or disease. The gradual adoption and integration of 
these approaches in future exposure assessment studies may enable the public health 
community to rapidly characterize the physiologic host response to inhalation exposures 
of different sources, and to evaluate the biologic consequences of exposure-reduction 
initiatives, thereby helping us address some of the greatest public health challenges of our 
time.  
 
 
	  	   95 
LIST OF JOURNAL ABBREVIATIONS 
 
Addict. Abingdon Engl. Addiction (Abingdon, England) 
  
Addict. Behav. Addictive Behaviors 
  
Am. J. Epidemiol. American Journal of Epidemiology 
  
Am. J. Phys. American Journal of Physiology 
  
Am. J. Phys. Lung Cell. Mol. 
Physiol. 
American Journal of Physiology - Lung Cellular 
and Molecular Physiology  
  
Am. J. Prev. Med. American Journal of Preventive Medicine 
  
Am. J. Public Health American Journal of Public Health 
  
Am. J. Respir. Crit. Care Med. American Journal of Respiratory and Critical Care Medicine 
  
Am. Rev. Respir. Dis. American Review of Respiratory Diseases 
  
Ann. Statist. Annals of Statistics 
  
Annu Rev. Energy Environ. Annual Review of Energy and the Environment  
  
Annu. Rev. Neurosci. Annual Review of Neuroscience 
  
Arch. Biochem. Biophys.  Archives of Biochemistry and Biophysics 
  
Arch. Environ. Health Archives of Environmental Health 
  
Br. J. Cancer British Journal of Cancer 
  
Cancer Epidemiol. 
Biomarkers Prev. Cancer Epidemiology, Biomarkers & Prevention            
 
Cancer Prev. Res. 
 
Cancer Prevention Research 
  
 
	  	   96 
Cancer Res. Cancer Research 
 
Chem. Res. Toxicol. Chemical Research in Toxicology 
  
Clin. Chem. Clinical Chemistry 
  
Clin. Exp. Allergy  Clinical & Experimental Allergy 
  
Cold Spring Harb. Perspect. 
Biol.  Cold Spring Harbor Perspectives in Biology 
  
Curr. Allergy Asthma Rep. Current Allergy and Asthma Reports 
  
Curr. Opin. Biotechnol. Current Opinion in Biotechnology  
  
Drug Metab. Dispos. Biol. 
Fate Chem.  
Drug Metabolism and Disposition: The Biological 
Fate of Chemicals 
  
Environ. Health Perspect. Environmental Health Perspectives 
  
Environ. Int. Environmental International 
  
Environ. Mol. Mutagen. Environmental and Molecular Mutagenesis 
  
Environ. Res. Environmental Research 
  
Environ. Sci. Tech. Environmental Science and Technology 
  
Epidemiol. Rev. Epidemiologic Reviews 
  
Eur. J. Epidemiol. European Journal of Epidemiology 
  
Eur. J. Pediatr. European Journal of Pediatrics  
  
Eur. Respir. J. European Respiratory Journal 
  
Food Chem. Toxicol. Food and Chemical Toxicology 
  
Front. Genet. Frontiers in Genetics 
  
Genome Biol. Genome Biology 
	  	   97 
Genome Res. Genome Research 
  
Int. J. Epidemiol. International Journal of Epidemiology 
  
J. Biol. Chem.  Journal of Biological Chemistry 
  
J. Clin. Epidemiol. Journal of Clinical Epidemiology 
  
J. Clin. Oncol. Journal of Clinical Oncology 
  
J. Comput. Biol. Journal of Computational Biology 
  
J. Environ. Monit. Journal of Environmental Monitoring 
  
J. Expo. Sci. Environ. 
Epidemiol.  
Journal of Exposure Science and Environmental 
Epidemiology 
  
J. Immunol.  Journal of Immunology 
  
J. Lab. Clin. Med.  Journal of Laboratory and Clinical Medicine 
  
J. Mol. Med. Journal of Molecular Medicine 
  
J. Natl. Cancer Inst.  Journal of the National Cancer Institute 
  
J. Nurs. Meas. Journal of Nursing Management 
  
J. Oncol. Journal of Oncology 
  
J. Pharmacol. Exp. Ther. Journal of Pharmacology and Experimental Therapeutics 
  
J. R. Stat. Soc. Journal of the Royal Statistical Society 
  
J. Surg. Res. Journal of Surgical Research 
  
Korean J. Pediatr. Korean Journal of Pediatrics 
  
Lancet Oncol. Lancet Oncology 
  
Matern. Child Health J. Maternal and Child Health Journal 
	  	   98 
Med. Care Medical Care 
  
Mediators Inflamm.  Mediators of Inflammation 
  
Methods Mol. Biol. Methods in Molecular Biology 
  
MMWR Morb. Mortal. Wkly. 
Rep. Morbidity and Mortality Weekly Report 
  
Mol. Biol. Cell Molecular Biology of the Cell 
  
Mutat. Res. Mol. Mech. 
Mutagen.  
Mutation Research: Fundamental and Molecular  
Mechanisms of Mutagenesis 
  
N. Engl. J. Med.  New England Journal of Medicine 
  
Nat. Cell Biol. Nature Cell Biology 
  
Nat. Genet. Nature Genetics 
  
Nat. Med. Nature Medicine 
  
Nat. Protoc. Nature Protocols 
  
Nicotine Tob. Res. Nicotine and Tobacco Research 
  
Nucleic Acids Res. Nucleic Acids Research 
  
Physiol. Genomics Physiological Genomics 
  
PLOS Comput. Biol. PLOS Computational Biology 
  
PLOS Genet. PLOS Genetics 
  
Popul. Health. Manag. Population Health Management 
  
Prev. Med. Preventive Medicine 
  
Proc. Natl. Acad. Sci. Proceedings of National Academy of Sciences 
  
Regul. Toxicol. Pharmacol. Regulatory Toxicology and Pharmacology 
	  	   99 
Risk Anal. Risk Analysis 
  
Sci. Tot. Environ. Science of the Total Environment 
  
Tob. Control Tobacco Control 
  
Tob. Induc. Dis. Tobacco Induced Diseases 
  
Toxicol. Appl. Pharmacol.  Toxicology and Applied Pharmacology 
  
Vital Heal. Stat. Vital and Health Statistics  
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
	  	   100 
BIBLIOGRAPHY 
 
1. Willingham, A. T. & Gingeras, T. R. TUF Love for ‘Junk’ DNA. Cell 125, 1215–1220 
(2006). 	  
2. Golub, T. R. et al. Molecular classification of cancer: class discovery and class 
prediction by gene expression monitoring. Science 286, 531–537 (1999). 	  
3. Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression 
profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U. S. A. 
98, 13790–13795 (2001). 	  
4. Spira, A. et al. Airway epithelial gene expression in the diagnostic evaluation of 
smokers with suspect lung cancer. Nat. Med. 13, 361–366 (2007). 	  
5. Van de Vijver, M. J. et al. A Gene-Expression Signature as a Predictor of Survival in 
Breast Cancer. N. Engl. J. Med. 347, 1999–2009 (2002). 	  
6. Evans, W. E. & Guy, R. K. Gene expression as a drug discovery tool. Nat. Genet. 36, 
214–215 (2004). 	  
7. Wild, C. P. Complementing the Genome with an ‘Exposome’: The Outstanding 
Challenge of Environmental Exposure Measurement in Molecular Epidemiology. 
Cancer Epidemiol. Biomarkers Prev. 14, 1847–1850 (2005). 	  
8. Rappaport, S. M. & Smith, M. T. Environment and Disease Risks. Science 330, 460–
461 (2010). 	  
9. Vrijheid, M. The exposome: a new paradigm to study the impact of environment on 
health. Thorax 69, 876–878 (2014). 	  
10. Wild, C. P. The exposome: from concept to utility. Int. J. Epidemiol. 41, 24–32 
(2012). 	  
11. Rappaport, S. M. Implications of the exposome for exposure science. J. Expo. Sci. 
Environ. Epidemiol. 21, 5–9 (2011). 	  
12. National Research Council. Exposure Science in the 21st Century: A Vision And A 
Strategy. (2012). 	  
13. Coughlin, S. S. Toward a road map for global -omics: a primer on -omic 
technologies. Am. J. Epidemiol. 180, 1188–1195 (2014). 	  
	  	   101 
14. Garte, S. J. Molecular environmental biology. (Lewis Publishers, 1994). 	  
15. Flavell, S. W. & Greenberg, M. E. Signaling mechanisms linking neuronal activity to 
gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563–
590 (2008). 	  
16. Rogue, A., Lambert, C., Spire, C., Claude, N. & Guillouzo, A. Interindividual 
Variability in Gene Expression Profiles in Human Hepatocytes and Comparison with 
HepaRG Cells. Drug Metab. Dispos. 40, 151–158 (2012). 	  
17. Idaghdour, Y. & Awadalla, P. Exploiting Gene Expression Variation to Capture 
Gene-Environment Interactions for Disease. Front. Genet. 3, (2013). 	  
18. Wild, C. P., Scalbert, A. & Herceg, Z. Measuring the exposome: A powerful basis for 
evaluating environmental exposures and cancer risk: The Exposome and Cancer 
Risk. Environ. Mol. Mutagen. 54, 480–499 (2013). 	  
19. Spira, A. et al. Effects of cigarette smoke on the human airway epithelial cell 
transcriptome. Proc. Natl. Acad. Sci. U. S. A. 101, 10143–10148 (2004). 	  
20. Beane, J. et al. Reversible and permanent effects of tobacco smoke exposure on 
airway epithelial gene expression. Genome Biol. 8, R201 (2007). 	  
21. Steiling K et al. A dynamic bronchial airway gene expression signature of COPD and 
lung function impairment. Am J Resp Crit Care Med In Press, (2013). 	  
22. Sridhar, S. et al. Smoking-induced gene expression changes in the bronchial airway 
are reflected in nasal and buccal epithelium. Bmc Genomics 9, 259 (2008). 	  
23. Zhang, X. et al. Similarities and differences between smoking-related gene 
expression in nasal and bronchial epithelium. Physiol Genomics 41, 1–8 (2010). 	  
24. Göhlmann, H. Gene expression studies using affymetrix microarrays. (Taylor & 
Francis, 2009). 	  
25. Zhu, S. et al. Mouse liver repopulation with hepatocytes generated from human 
fibroblasts. Nature 508, 93–97 (2014). 	  
26. Chatterjee, T. K. et al. Human coronary artery perivascular adipocytes overexpress 
genes responsible for regulating vascular morphology, inflammation, and hemostasis. 
Physiol. Genomics 45, 697–709 (2013). 	  
	  	   102 
27. Orecchioni, S. et al. Complementary Populations of Human Adipose CD34+ 
Progenitor Cells Promote Growth, Angiogenesis, and Metastasis of Breast Cancer. 
Cancer Res. 73, 5880–5891 (2013). 	  
28. Mutz, K.-O., Heilkenbrinker, A., Lönne, M., Walter, J.-G. & Stahl, F. Transcriptome 
analysis using next-generation sequencing. Curr. Opin. Biotechnol. 24, 22–30 (2013). 	  
29. Affymetrix. GeneChip Gene 1.0 ST Array System for Huma, Mouse and Rat. at 
<www.affymetrix.com> 	  
30. Hecht, S. S. Cigarette smoking and lung cancer: chemical mechanisms and 
approaches to prevention. Lancet Oncol. 3, 461–469 (2002). 	  
31. Smith, C. J., Perfetti, T. A., Garg, R. & Hansch, C. IARC carcinogens reported in 
cigarette mainstream smoke and their calculated log P values. Food Chem. Toxicol. 
Int. J. Publ. Br. Ind. Biol. Res. Assoc. 41, 807–817 (2003). 	  
32. U.S. Department of Health, Education, and Welfare. Smoking and Health: Report of 
the Advisory Committee to the Surgeon General of the Public Health Service. (1964). 	  
33. U.S. Department of Health and Human Services. The Health Consequences of 
Smoking - 50 Years of Progress: A Report of the Surgeon General. (2014). 	  
34. Centers for Disease Control and Prevention (CDC). Vital signs: nonsmokers’ 
exposure to secondhand smoke --- United States, 1999-2008. Mmwr Morb. Mortal. 
Wkly. Rep. 59, 1141–1146 (2010). 	  
35. Goniewicz, M. L. et al. Comparison of Urine Cotinine and the Tobacco-Specific 
Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) and 
Their Ratio to Discriminate Active From Passive Smoking. Nicotine Tob. Res. 13, 
202–208 (2011). 	  
36. United States. The health consequences of involuntary exposure to tobacco smoke: a 
report of the Surgeon General. (U.S. Dept. of Health and Human Services, Public 
Health Service, Office of the Surgeon General, 2006). 	  
37. Ciaccio, C. E. & Gentile, D. Effects of Tobacco Smoke Exposure in Childhood on 
Atopic Diseases. Curr. Allergy Asthma Rep. 13, 687–692 (2013). 	  
38. Cheraghi, M. & Salvi, S. Environmental tobacco smoke (ETS) and respiratory health 
in children. Eur. J. Pediatr. 168, 897–905 (2009). 	  
39. Environmental Toxicology. (Springer New York, 2013). at 
<http://link.springer.com/10.1007/978-1-4614-5764-0>. 
	  	   103 
40. Hwang, S.-H., Hwang, J. H., Moon, J. S. & Lee, D.-H. Environmental tobacco smoke 
and children’s health. Korean J. Pediatr. 55, 35 (2012). 	  
41. Patrick, D. L. et al. The validity of self-reported smoking: a review and meta-
analysis. Am. J. Public Health 84, 1086–1093 (1994). 
 
42. Fendrich, M., Mackesy-Amiti, M. E., Johnson, T. P., Hubbell, A. & Wislar, J. S. 
Tobacco-reporting validity in an epidemiological drug-use survey. Addict. Behav. 30, 
175–181 (2005). 	  
43. Klebanoff, M. A., Levine, R. J., Clemens, J. D., DerSimonian, R. & Wilkins, D. G. 
Serum cotinine concentration and self-reported smoking during pregnancy. Am. J. 
Epidemiol. 148, 259–262 (1998). 	  
44. Steffen, M. W. et al. Self-report of tobacco use status: comparison of paper-based 
questionnaire, online questionnaire, and direct face-to-face interview--implications 
for meaningful use. Popul. Heal. Manag. 17, 185–189 (2014). 	  
45. Gaffney, K. F., Molloy, S. B. & Maradiegue, A. H. Questionnaires for the 
measurement of infant environmental tobacco smoke exposure: a systematic review. 
J. Nurs. Meas. 11, 225–239 (2003). 	  
46. Yeager, D. S. & Krosnick, J. A. The validity of self-reported nicotine product use in 
the 2001-2008 National Health and Nutrition Examination Survey. Med. Care 48, 
1128–1132 (2010). 	  
47. Means, B., Habina, K., Swan, G. & Jack, L. Cognitive research on response error in 
survey questions on smoking. Vital Heal. Stat. 6, (1992). 	  
48. Cummings, S. R. & Richard, R. J. Optimum cutoff points for biochemical validation 
of smoking status. Am. J. Public Health 78, 574–575 (1988). 	  
49. Ozdener, M. et al. Assessment of smoking status based on cotinine levels in nasal 
lavage fluid. Tob. Induc. Dis. 5, 11 (2009). 	  
50. Jaakkola, M. S. & Jaakkola, J. J. K. Assessment of exposure to environmental 
tobacco smoke. Eur. Respir. J. 10, 2384–2397 (1997). 	  
51. Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C. & Saloojee, Y. 
Comparison of tests used to distinguish smokers from nonsmokers. Am. J. Public 
Health 77, 1435–1438 (1987). 	  
52. Abrams, D. B., Follick, M. J., Biener, L., Carey, K. B. & Hitti, J. Saliva cotinine as a 
measure of smoking status in field settings. Am. J. Public Health 77, 846–848 (1987). 
	  	   104 
53. Caraballo, R. S., Giovino, G. A., Pechacek, T. F. & Mowery, P. D. Factors associated 
with discrepancies between self-reports on cigarette smoking and measured serum 
cotinine levels among persons aged 17 years or older: Third National Health and 
Nutrition Examination Survey, 1988-1994. American journal of epidemiology 153, 
807–14 (2001). 	  
54. Pérez-Stable, E. J., Benowitz, N. L. & Marín, G. Is serum cotinine a better measure 
of cigarette smoking than self-report? Prev. Med. 24, 171–179 (1995). 	  
55. Pirkle, J. L. et al. Exposure of the US population to environmental tobacco smoke: 
the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 
275, 1233–1240 (1996). 	  
56. Wall, M. A., Johnson, J., Jacob, P. & Benowitz, N. L. Cotinine in the serum, saliva, 
and urine of nonsmokers, passive smokers, and active smokers. Am. J. Public Health 
78, 699–701 (1988). 	  
57. Benowitz, N. L. Cotinine as a biomarker of environmental tobacco smoke exposure. 
Epidemiol. Rev. 18, 188–204 (1996). 	  
58. Avila-Tang, E. et al. Assessing secondhand smoke using biological markers. Tob. 
Control (2012). doi:10.1136/tobaccocontrol-2011-050298. 	  
59. Rylander, E., Pershagen, G., Eriksson, M. & Nordvall, L. Parental smoking and other 
risk factors for wheezing bronchitis in children. Eur. J. Epidemiol. 9, 517–526 
(1993). 	  
60. Nafstad, P. et al. Comparison of three methods for estimating environmental tobacco 
smoke exposure among children aged between 12 and 36 months. Int. J. Epidemiol. 
24, 88–94 (1995). 	  
61. Idle, J. R. Titrating exposure to tobacco smoke using cotinine--a minefield of 
misunderstandings. J. Clin. Epidemiol. 43, 313–317 (1990). 	  
62. Gorini, G., Gasparrini, A., Fondelli, M. C. & Invernizzi, G. Secondhand smoke 
markers: review of methods for monitoring exposure levels. (2005). 	  
63. Batterman, S., Metts, T. & Kalliokoski, P. Diffusive uptake in passive and active 
adsorbent sampling using thermal desorption tubes. J. Environ. Monit. Jem 4, 870–
878 (2002). 	  
64. Apelberg, B. J. et al. Environmental monitoring of secondhand smoke exposure. Tob. 
Control (2012). doi:10.1136/tobaccocontrol-2011-050301. 
	  	   105 
65. Beane, J. et al. SIRT1 pathway dysregulation in the smoke-exposed airway 
epithelium and lung tumor tissue. Cancer Res. 72, 5702–5711 (2012). 	  
66. Bernert, J. T. et al. Development and validation of sensitive method for determination 
of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric 
pressure ionization tandem mass spectrometry. Clin. Chem. 43, 2281–2291 (1997). 	  
67. Dai, M. et al. Evolving gene/transcript definitions significantly alter the interpretation 
of GeneChip data. Nucleic Acids Res 33, e175 (2005). 	  
68. Benjamini. Controlling the false discovery rate: a practical and powerful approach to 
multiple hypothesis testing. J R Stat. Soc 57, (1995). 	  
69. Leek, J. T. & Storey, J. D. Capturing heterogeneity in gene expression studies by 
surrogate variable analysis. Plos Genet. 3, 1724–1735 (2007). 	  
70. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach 
for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S 102, 
15545–50 (2005). 	  
71. Campbell, J. Genome-wide characterization of microRNA and gene-expression 
patterns in smoking-related lung disease. (UMI Dissertation Publishing, 2012). 	  
72. Coultas, D. B., Samet, J. M., McCarthy, J. F. & Spengler, J. D. Variability of 
Measures of Exposure to Environmental Tobacco Smoke in the Home. Am. Rev. 
Respir. Dis. 142, 602–606 (1990). 	  
73. Kemmeren, J. M., van Poppel, G., Verhoef, P. & Jarvis, M. J. Plasma cotinine: 
stability in smokers and validation of self-reported smoke exposure in nonsmokers. 
Environ. Res. 66, 235–243 (1994). 	  
74. Dunn, A., Satcher, D. & Zeise, L. Health Effects of Exposure to Environmental 
Tobacco Smoke: The Report of the California Environmental Protection Agency. 
(U.S. Department of Health and Human Services, National Institutes of Health, 
National Cancer Institue, NIH Pub., 1999). 	  
75. Coultas, D. B., Howard, C. A., Peake, G. T., Skipper, B. J. & Samet, J. M. Salivary 
Cotinine Levels and Involuntary Tobacco Smoke Exposure in Children and Adults in 
New Mexico. Am. Rev. Respir. Dis. 136, 305–309 (1987). 	  
76. LaKind, J. S. et al. Use of environmental tobacco smoke constituents as markers for 
exposure. Risk Anal. Off. Publ. Soc. Risk Anal. 19, 359–373 (1999). 	  
	  	   106 
77. Butz, A. M. et al. Household Smoking Behavior: Effects on Indoor Air Quality and 
Health of Urban Children with Asthma. Matern. Child Health J. 15, 460–468 (2011). 	  
78. Leong, J. W. et al. The elimination half-life of urinary cotinine in children of 
tobacco-smoking mothers. Pulm. Pharmacol. Ther. 11, 287–290 (1998). 	  
79. Zhang, X., Liu, G., Lenburg, M. E. & Spira, A. Comparison of smoking-induced 
gene expression on Affymetrix Exon and 3’-based expression arrays. Genome 
Informatics Int. Conf. Genome Informatics 18, 247–257 (2007). 	  
80. Jorgensen, E. et al. Cigarette smoke induces endoplasmic reticulum stress and the 
unfolded protein response in normal and malignant human lung cells. Bmc Cancer 8, 
229 (2008). 	  
81. Mathis, C. et al. Human bronchial epithelial cells exposed in vitro to cigarette smoke 
at the air-liquid interface resemble bronchial epithelium from human smokers. Am. J. 
Physiol. Lung Cell. Mol. Physiol. 304, L489–503 (2013). 	  
82. Reproductive and developmental toxicology. (Elsevier/Academic Press, 2011). 	  
83. Bajaj, M. Nicotine and Insulin Resistance: When the Smoke Clears. Diabetes 61, 
3078–3080 (2012). 	  
84. Hofstetter, A., Schutz, Y., Jéquier, E. & Wahren, J. Increased 24-hour energy 
expenditure in cigarette smokers. N. Engl. J. Med. 314, 79–82 (1986). 	  
85. Kohler, S. et al. The Human Phenotype Ontology project: linking molecular biology 
and disease through phenotype data. Nucleic Acids Res. 42, D966–D974 (2014). 	  
86. Nagaraj, N. S. et al. Cigarette smoke condensate induces cytochromes P450 and aldo-
keto reductases in oral cancer cells. Toxicol. Lett. 165, 182–194 (2006). 	  
87. Park, J.-H. et al. Evidence for the aldo-keto reductase pathway of polycyclic aromatic 
trans-dihydrodiol activation in human lung A549 cells. Proc. Natl. Acad. Sci. 105, 
6846–6851 (2008). 	  
88. Ezzati, M. & Kammen, D. M. HOUSEHOLD ENERGY, INDOOR AIR 
POLLUTION, AND HEALTH IN DEVELOPING COUNTRIES: Knowledge Base 
for Effective Interventions. Annu. Rev. Energy Environ. 27, 233–270 (2002). 	  
89. Ezzati, M. & Kammen, D. M. Indoor air pollution from biomass combustion and 
acute respiratory infections in Kenya: an exposure-response study. The Lancet 358, 
619–624 (2001). 
	  	   107 
90. Smith, K. R., Samet, J. M., Romieu, I. & Bruce, N. Indoor air pollution in developing 
countries and acute lower respiratory infections in children. Thorax 55, 518–532 
(2000). 	  
91. Zhang, Z. F., Yu, S. Z. & Zhou, G. D. Indoor air pollution of coal fumes as a risk 
factor of stroke, Shanghai. Am. J. Public Health 78, 975–977 (1988). 	  
92. Zhao, Y., Wang, S., Aunan, K., Seip, H. M. & Hao, J. Air pollution and lung cancer 
risks in China--a meta-analysis. Sci. Total Environ. 366, 500–513 (2006). 	  
93. World Health Organization. Burden of disease from Household Air Pollution for 
2012. (2014). at 
<http://www.who.int/phe/health_topics/outdoorair/databases/FINAL_HAP_AAP_Bo
D_24March2014.pdf> 	  
94. Zhang, J. & Smith, K. R. Household Air Pollution from Coal and Biomass Fuels in 
China: Measurements, Health Impacts, and Interventions. Environ. Health Perspect. 
115, 848–855 (2007). 	  
95. Mumford, J. L. et al. Lung cancer and indoor air pollution in Xuan Wei, China. 
Science 235, 217–220 (1987). 	  
96. Chapman, R. S. et al. The epidemiology of lung cancer in Xuan Wei, China: current 
progress, issues, and research strategies. Arch. Environ. Health 43, 180–185 (1988). 	  
97. Barone-Adesi, F. et al. Risk of lung cancer associated with domestic use of coal in 
Xuanwei, China: retrospective cohort study. BMJ 345, e5414–e5414 (2012). 	  
98. Chapman, R. S. Improvement in household stoves and risk of chronic obstructive 
pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ 331, 1050–0 
(2005). 	  
99. Lan, Q., Chapman, R. S., Schreinemachers, D. M., Tian, L. & He, X. Household 
stove improvement and risk of lung cancer in Xuanwei, China. J. Natl. Cancer Inst. 
94, 826–835 (2002). 	  
100. Lan, Q. et al. Smoky coal exposure, NBS1 polymorphisms, p53 protein 
accumulation, and lung cancer risk in Xuan Wei, China. Lung Cancer 49, 317–323 
(2005). 	  
101. Downward, G. S. et al. Heterogeneity in coal composition and implications for lung 
cancer risk in Xuanwei and Fuyuan counties, China. Environ. Int. 68, 94–104 (2014). 
	  	   108 
102. Downward, G. S. et al. Polycyclic Aromatic Hydrocarbon Exposure in Household 
Air Pollution from Solid Fuel Combustion among the Female Population of Xuanwei 
and Fuyuan Counties, China. Environ. Sci. Technol. 48, 14632–14641 (2014). 	  
103. Hosgood, H. D. et al. Portable stove use is associated with lower lung cancer 
mortality risk in lifetime smoky coal users. Br. J. Cancer 99, 1934–1939 (2008). 	  
104. Bao, P. et al. The Role of Vascular Endothelial Growth Factor in Wound Healing. J. 
Surg. Res. 153, 347–358 (2009). 	  
105. Hicklin, D. J. Role of the Vascular Endothelial Growth Factor Pathway in Tumor 
Growth and Angiogenesis. J. Clin. Oncol. 23, 1011–1027 (2004). 	  
106. Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-
driven cancers require TBK1. Nature 462, 108–112 (2009). 	  
107. DeMarini, D. M. et al. Lung tumor KRAS and TP53 mutations in nonsmokers 
reflect exposure to PAH-rich coal combustion emissions. Cancer Res. 61, 6679–6681 
(2001). 	  
108. Boyle, J. O. et al. Effects of Cigarette Smoke on the Human Oral Mucosal 
Transcriptome. Cancer Prev. Res. (Phila. Pa.) 3, 266–278 (2010). 	  
109. Hu, W. et al. Personal and Indoor PM2.5 Exposure from Burning Solid Fuels in 
Vented and Unvented Stoves in a Rural Region of China with a High Incidence of 
Lung Cancer. Environ. Sci. Technol. 48, 8456–8464 (2014). 	  
110. Spira, A. et al. Noninvasive method for obtaining RNA from buccal mucosa 
epithelial cells for gene expression profiling. BioTechniques 36, 484–487 (2004). 
111. Gentleman, R. C. et al. Bioconductor: open software development for computational 
biology and bioinformatics. Genome Biol. 5, R80 (2004). 	  
112. Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list 
enrichment analysis tool. BMC Bioinformatics 14, 128 (2013). 	  
113. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. 
Nucleic Acids Res. 28, 27–30 (2000). 	  
114. Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 
25, 25–29 (2000). 	  
115. Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 
1739–1740 (2011). 
	  	   109 
116. Edgar R, Domrachev M & Lash AE. Gene Expression Omnibus: NCBI gene 
expression and hybridization array data repository. Nucleic Acids Res. 30, 207–210 
(2002). 	  
117. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative 
CT method. Nat. Protoc. 3, 1101–1108 (2008). 	  
118. Casale, G. P. et al. Detection and quantification of depurinated benzo[a]pyrene-
adducted DNA bases in the urine of cigarette smokers and women exposed to 
household coal smoke. Chem. Res. Toxicol. 14, 192–201 (2001). 	  
119. Granville, C. A., Hanley, N. M., Mumford, J. L. & DeMarini, D. M. Mutation 
spectra of smoky coal combustion emissions in Salmonella reflect the TP53 and 
KRAS mutations in lung tumors from smoky coal-exposed individuals. Mutat. Res. 
Mol. Mech. Mutagen. 525, 77–83 (2003). 	  
120. Lan, Q. & He, X. Molecular epidemiological studies on the relationship between 
indoor coal burning and lung cancer in Xuan Wei, China. Toxicology 198, 301–305 
(2004). 	  
121. Mumford, J. L., Li, X., Hu, F., Lu, X. B. & Chuang, J. C. Human exposure and 
dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with 
high lung cancer mortality associated with exposure to unvented coal smoke. 
Carcinogenesis 16, 3031–3036 (1995). 	  
122. Mumford, J. L., Lee, X., Lewtas, J., Young, T. L. & Santella, R. M. DNA Adducts 
As Biomarkers for Assessing Exposure to Polycyclic Aromatic Hydrocarbons in 
Tissues from Xuan Wei Women with High Exposure to Coal Combustion Emissions 
and High Lung Cancer Mortality. Environ. Health Perspect. 99, 83 (1993). 	  
123. Vineis, P. Air pollution and cancer: biomarker studies in human populations. 
Carcinogenesis 26, 1846–1855 (2005). 	  
124. Becker, S., Dailey, L., Soukup, J. M., Silbajoris, R. & Devlin, R. B. TLR-2 is 
involved in airway epithelial cell response to air pollution particles. Toxicol. Appl. 
Pharmacol. 203, 45–52 (2005). 	  
125. Hiraiwa, K. & van Eeden, S. F. Contribution of Lung Macrophages to the 
Inflammatory Responses Induced by Exposure to Air Pollutants. Mediators Inflamm. 
2013, 1–10 (2013). 	  
126. Carter, J. D., Ghio, A. J., Samet, J. M. & Devlin, R. B. Cytokine production by 
human airway epithelial cells after exposure to an air pollution particle is metal-
dependent. Toxicol. Appl. Pharmacol. 146, 180–188 (1997). 
	  	   110 
127. Jaspers, I., Flescher, E. & Chen, L. C. Ozone-induced IL-8 expression and 
transcription factor binding in respiratory epithelial cells. Am. J. Physiol. 272, L504–
511 (1997). 	  
128. Lu, Y. et al. Characteristics and cellular effects of ambient particulate matter from 
Beijing. Environ. Pollut. 191, 63–69 (2014). 	  
129. Scarpa, M. C., Kulkarni, N. & Maestrelli, P. The role of non-invasive biomarkers in 
detecting acute respiratory effects of traffic-related air pollution. Clin. Exp. Allergy 
44, 1100–1118 (2014). 	  
130. Dutta, A., Ray, M. R. & Banerjee, A. Systemic inflammatory changes and increased 
oxidative stress in rural Indian women cooking with biomass fuels. Toxicol. Appl. 
Pharmacol. 261, 255–262 (2012). 	  
131. Beane, J. et al. Characterizing the Impact of Smoking and Lung Cancer on the 
Airway Transcriptome Using RNA-Seq. Cancer Prev. Res. (Phila. Pa.) 4, 803–817 
(2011). 	  
132. McIlwain, D. R., Berger, T. & Mak, T. W. Caspase Functions in Cell Death and 
Disease. Cold Spring Harb. Perspect. Biol. 5, a008656–a008656 (2013). 	  
133. Fulda, S. Tumor resistance to apoptosis. Int. J. Cancer 124, 511–515 (2009). 
134. Fennell, D. A. Caspase Regulation in Non-Small Cell Lung Cancer and its Potential 
for Therapeutic Exploitation. Clin. Cancer Res. 11, 2097–2105 (2005). 	  
135. Courcot, E. et al. Xenobiotic metabolism and disposition in human lung cell models: 
comparison with in vivo expression profiles. Drug Metab. Dispos. Biol. Fate Chem. 
40, 1953–1965 (2012). 	  
136. Hegab, A. E. CLCA1 gene polymorphisms in chronic obstructive pulmonary 
disease. J. Med. Genet. 41, 27e–27 (2004). 	  
137. Wilk, J. B. et al. A Genome-Wide Scan of Pulmonary Function Measures in the 
National Heart, Lung, and Blood Institute Family Heart Study. Am. J. Respir. Crit. 
Care Med. 167, 1528–1533 (2003). 	  
138. Hegab, A. E. et al. Niflumic acid and AG-1478 reduce cigarette smoke-induced 
mucin synthesis: the role of hCLCA1. Chest 131, 1149–1156 (2007). 
139. Kim, C. et al. Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, 
China. Lung Cancer 84, 31–35 (2014). 	  
	  	   111 
140. Lee, K.-M. et al. Differential effects of smoking on lung cancer mortality before and 
after household stove improvement in Xuanwei, China. Br. J. Cancer 103, 727–729 
(2010). 	  
141. Silverman, D. T. et al. The Diesel Exhaust in Miners Study: A Nested Case-Control 
Study of Lung Cancer and Diesel Exhaust. Jnci J. Natl. Cancer Inst. 104, 855–868 
(2012). 	  
142. King, B. A., Alam, S., Promoff, G., Arrazola, R. & Dube, S. R. Awareness and 
Ever-Use of Electronic Cigarettes Among U.S. Adults, 2010-2011. Nicotine Tob. 
Res. 15, 1623–1627 (2013). 	  
143. King, B. A., Patel, R., Nguyen, K. H. & Dube, S. R. Trends in Awareness and Use 
of Electronic Cigarettes Among US Adults, 2010-2013. Nicotine Tob. Res. 17, 219–
227 (2015). 	  
144. Food and Drug Administration. Deeming Tobacco Products To Be Subject to the 
Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking 
Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of 
Tobacco Products and Required Warning Statements for Tobacco Products. (2014). 
at <https://www.federalregister.gov/>. 	  
145. Marynak, K. et al. State laws prohibiting sales to minors and indoor use of 
electronic nicotine delivery systems--United States, November 2014. Mmwr Morb. 
Mortal. Wkly. Rep. 63, 1145–1150 (2014). 	  
146. Arrazola, R. A. et al. Tobacco use among middle and high school students--United 
States, 2013. Mmwr Morb. Mortal. Wkly. Rep. 63, 1021–1026 (2014). 	  
147. Brandon, T. H. et al. Electronic Nicotine Delivery Systems: A Policy Statement 
from the American Association for Cancer Research and the American Society of 
Clinical Oncology. Clin. Cancer Res. 21, 514–525 (2015). 	  
148. Goniewicz, M. L., Hajek, P. & McRobbie, H. Nicotine content of electronic 
cigarettes, its release in vapour and its consistency across batches: regulatory 
implications. Addict. Abingdon Engl. 109, 500–507 (2014). 	  
149. Fulcher, M. L., Gabriel, S., Burns, K. A., Yankaskas, J. R. & Randell, S. H. Well-
differentiated human airway epithelial cell cultures. Methods Mol. Med. 107, 183–
206 (2005). 	  
150. Chu, H. W. et al. Transforming growth factor-beta2 induces bronchial epithelial 
mucin expression in asthma. Am. J. Pathol. 165, 1097–1106 (2004). 
	  	   112 
151. Farsalinos, K. E. et al. Nicotine absorption from electronic cigarette use: 
comparison between first and new-generation devices. Sci. Reports 4, 4133 (2014). 	  
152. Electronic Cigarettes. JAMA 311, 195 (2014). 	  
153. Behar, R. Z., Hua, M. & Talbot, P. Puffing Topography and Nicotine Intake of 
Electronic Cigarette Users. Plos One 10, e0117222 (2015). 	  
154. Tayyarah, R. & Long, G. A. Comparison of select analytes in aerosol from e-
cigarettes with smoke from conventional cigarettes and with ambient air. Regul. 
Toxicol. Pharmacol. 70, 704–710 (2014). 	  
155. Hessel, J. et al. Intraflagellar transport gene expression associated with short cilia in 
smoking and COPD. Plos One 9, e85453 (2014). 	  
156. Martin, L. & Gardner, L. B. Stress-induced inhibition of nonsense-mediated RNA 
decay regulates intracellular cystine transport and intracellular glutathione through 
regulation of the cystine/glutamate exchanger SLC7A11. Oncogene (2014). 
doi:10.1038/onc.2014.352. 	  
157. Lerner, C. A. et al. Vapors Produced by Electronic Cigarettes and E-Juices with 
Flavorings Induce Toxicity, Oxidative Stress, and Inflammatory Response in Lung 
Epithelial Cells and in Mouse Lung. Plos One 10, e0116732 (2015). 	  
158. Waxman, D. J. et al. Steroid hormone hydroxylase specificities of eleven cDNA-
expressed human cytochrome P450s. Arch. Biochem. Biophys. 290, 160–166 (1991). 	  
159. Hukkanen, J. Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in 
Human Lung-Derived Cells. J. Pharmacol. Exp. Ther. 304, 745–752 (2003). 	  
160. Palackal, N. T., Lee, S. H., Harvey, R. G., Blair, I. A. & Penning, T. M. Activation 
of Polycyclic Aromatic Hydrocarbontrans-Dihydrodiol Proximate Carcinogens by 
Human Aldo-keto Reductase (AKR1C) Enzymes and Their Functional 
Overexpression in Human Lung Carcinoma (A549) Cells. J. Biol. Chem. 277, 24799–
24808 (2002). 	  
161. Meyer, K. C. et al. Tryptophan metabolism in chronic inflammatory lung disease. J. 
Lab. Clin. Med. 126, 530–540 (1995). 	  
162. Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl 
hydrocarbon receptor. Nature 478, 197–203 (2011). 	  
163. Mezrich, J. D. et al. An Interaction between Kynurenine and the Aryl Hydrocarbon 
Receptor Can Generate Regulatory T Cells. J. Immunol. 185, 3190–3198 (2010). 
	  	   113 
164. Picciotto, M. R. & Kenny, P. J. Molecular mechanisms underlying behaviors related 
to nicotine addiction. Cold Spring Harb. Perspect. Med. 3, a012112 (2013). 	  
165. Heijink, I. H. et al. Role of aberrant WNT signalling in the airway epithelial 
response to cigarette smoke in chronic obstructive pulmonary disease. Thorax 68, 
709–716 (2013). 
 
166. Lemjabbar-Alaoui, H. et al. Wnt and Hedgehog Are Critical Mediators of Cigarette 
Smoke-Induced Lung Cancer. Plos One 1, e93 (2006). 
	  	   114 
CURRICULUM VITAE 
Teresa Wei Wang 	  	  
Contact Information 
65 Chester St. 
Allston, MA 02134 
wateresa@bu.edu 
 	  
Education 
	  
2010-2015 Boston University, Boston, MA 
  Spira-Lenburg Lab, Section of Computational Biomedicine 
  Ph.D. Bioinformatics 
 
2013 Boston University, Boston, MA 
  M.S. Bioinformatics 
 
2006-2010 University of Michigan, Ann Arbor, MI 
  B.S.E. Biomedical Engineering, Biochemical Concentration 
	  
	  
 
Publications  
 
T Wang, R Vermeulen, W Hu, G Liu, X Xiao, Y Alekseyev, J Xu, B Reiss, K Steiling, G 
Downward, D Silverman, F Wei, G Wu, J Li, M Lenburg, N Rothman, A Spira, Q Lan. 
Gene-expression profiling of buccal epithelium among nonsmoking women exposed to 
household air pollution from smoky coal. In preparation. 
 
B Kusko, C Garrison, T Wang, J Campbell, J Perez-Rodgers, L Luo, J Beane, G Liu, H 
Kadara, S Belinsky, ME Lenburg, A Spira. miR-424 in never smokers. In preparation. 
 
B Berndt, M Zhang, SY Owyang, TS Cole, T Wang, J Luther, N Veniaminova, JL 
Merchant, CC Chen, GB Huffnagle, JY Kao. Butyrate increases IL-23 production by 
stimulated dendritic cells. Am J Physiol Gastrointest Liver Physiol. 2012 Dec. 
15;303(12):G1384-92. doi: 10.1152/ajpgi.00540.2011. 
 
 Patents 
 
A Spira, M Lenburg, R Kusko, C Garrison, T Wang, “MiR-424 and its regulated genes as 
therapeutic targets in never smoking lung adenocarcinoma,” U.S. Provisional Patent 
Application No. 61/973, 561 (2014). 
 
	  	   115 
Research Experience 
 
2014-2015  The Broad Institute, Cambridge, MA 
 Collaborator with Connectivity Map (CMAP) Team 
• Analyzed LINCS data generated in collaboration with Spira-Lenburg 
Lab to explore feasibility of a building a lung-oriented CMAP 
 
2010-2015 The Spira-Lenburg Lab, Section of Computational Biomedicine 
 Boston University School of Medicine, Boston, MA 
 PhD Candidate 
• Dissertation: Transcriptomics of the human airway epithelium reflect 
the physiologic response to inhaled environmental exposures 
 
2009  Regulus Rx, Carlsbad, CA 
 Summer Intern 
• Conducted in silico screen of GEO and in-house expression data for 
cardiac-specific miRNAs as potential therapeutic targets for heart 
disease 
 
2008-2009  Kao Lab, Immunology – University of Michigan Medical School 
 Undergraduate Research Fellow  
• Investigated therapeutic role of butyrate in inflammatory bowel 
disease (IBD) by examining mouse model of IBD 
• Learned and applied methods in primary cell culture, ELISA, and 
RT-PCR  
 
Selected Abstracts and Conference Presentations 
 
T Wang, D Brooks, Y Dumas, K Steiling, L Acosta, D Williams, RL Miller, M 
Perzanowski, F Perera, G Liu, X Xiao, Y Alekseyev, GB Diette, C Rodes, P 
Breysse, S Chillrud, M Lenburg, A Spira. Nasal gene expression profiling cap- 
tures the physiologic consequences of secondhand smoke exposure in children 
and adults. Paper Session 16. Biomarkers of Tobacco Use and Exposure. Society of 
Research for Nicotine and Tobacco. Philadelphia, PA. February 2015.  
 
T Wang, Q Lan, N Rothman, H Wei, K Steiling, G Liu, Y Alekseyev, HD Hos- 
good III, G Downward, B Reiss, F Wei, J Xu, M Lenburg, R Vermeulen, A Spira. 
Buccal epithelial gene-expression reflects the physiological response to smoky 
vs. smokeless coal exposure. Nanoparticles and (Epi)genetics. American Thoracic 
Society International Meeting, San Diego, CA. May 2014.  
 
R Kusko, C Garrison, T Wang, J Campbell, J Perez-Rogers, L Luo, J Beane, G 
Liu, H Kadara, S Belinsky, M Lenburg, A Spira. Gene and miRNA expression 
Networks specific to never smoker lung adenocarcinoma. American Association for 
	  	   116 
Cancer Research Annual Meeting, San Diego, CA. April 2014. 
 
T Wang. Characterizing the miRNA-mRNA network underlying never smoker 
lung cancer via RNAseq. Advances in Genome Biology and Technology, Marco Island, 
FL. February 2014. 
 
S Park, T Walser, C Perdomo, T Wang, P Pagano, E Liclican, K Krysan, J Larsen, M 
Fishbein, J Minna, M Lenburg, A Spira, S Dubinett. The effect of e-cigarette exposure on 
airway epithelial cell gene expression and transformation. Proceedings of the AACR-
IASLC Joint Conference on Molecular Origins of Lung Cancer; 2014 Jan 6-9; San Diego, 
CA. Philadelphia (PA): AACR; Clin Cancer Res 2014; 20(2Suppl):Abstract nr B16. 
 
T Wang, G Liu, YM Dumas, F Perera, D Brooks, SN Chillrud, ME Lenburg, 
A Spira. Secondhand smoke alters the nasal epithelial gene expression profiles in 
children and adults. A27. Smoke Signals on Pulmonary Cells: A1180. American Thoracic 
Society International Conference, Philadelphia, PA. May 2013. 
 
K Steiling, T Wang, J Campbell, G Liu, A LeClerc, Y Alekseyev, L Luo, J Xiao, 
X Zhang, D Sin, A McWilliams, S Lam, A Spira, ME Lenburg. Bronchial Airway 
MicroRNA expression associated with with Chronic Obstructive Pulmonary Disease. 
A27. Smoke Signals on Pulmonary Cells: A1201. American Thoracic Society 
International Conference, Philadelphia, PA. May 2013. 
 
R Kusko, J Perez-Rogers, T Wang, C Garrison, L Luo, C Tellez, G Liu, K Stel- 
ing, S Belinsky, J Beane, M Lenburg, A Spira. SEQing the shared and distinct 
transcriptional events underlying lung adenocarcinoma in smokers and nonsmokers. A27. 
Smoke Signals On Pulmonary Cells: A1196. American Association for Cancer Research 
Annual Meeting, Washington DC. April 2013. 
 
T Wang, JQ Lan, BK Malyszko, N Rothman, R Florido, W Hu, K Steiling, G 
Liu, J Xiao, Y Alekseyev, J Xu, F Wei, HD Hosgood, B Reiss, G Downward, ME 
Lenburg, R Vermeulen, A Spira. Transcriptomic changes in the oral mucosal 
epithelium reflect the physiologic response to indoor burning of solid fuels. 
American Association for Cancer Research Annual Meeting, Washington DC. April 
2013. 
 
T Wang, JD Campbell, L Luo, G Liu, J Xiao, ME Lenburg, SA Belinsky, A Spira . 
Deep sequencing of the microRNA transcriptome in current, former, and never 
smokers with lung adenocarcinoma. BMC Proceedings 2012 6(Suppl 6):P38. October 
2012. 
 
E Appleton, A Kar, T Wang, V Vasilev, J Yen, J Connor. Comparative gene 
expression analysis in non-human primates infected with anthrax, poxviruses, 
and filoviruses. NSF IGERT Annual PI Meeting Washington, DC. May 2012. 
	  	   117 
 
Fellowships and Awards 
 
2014  BU Bioinformatics Student Service Award 
2014  ATS Abstract Award, EOPH Assembly 
2013 Clinical/Patient-based Research Award, BU Evans Research Days  
2013-2015 BU NIH T-32 “Biology of the Lung” Fellowship 
2012-2014 TEDMED Scholar 
2010-2012 NSF IGERT Fellowship 
2009 UM College of Engineering Marian Sarah Parker Prize 
2006-2010 Sidney J and Irene Shipman Scholarship 
2006-2010 UM Engineering Class of 1948 Scholarship 
  
 
 
